Body Systems

Joints

Other NamesAmphiarthroses

Natural Remedies10

Ingredients308

Table of contents

Other Names

AmphiarthrosesAmphiarthrosisArthralArthrologiaArthrologyArticularArticular SystemArticulationesArticulationes ossiumArticulationsBony JointsCartilaginous JointsDiarthrodial JointsDiarthrosesDiarthrosisFibrous JointsJuncturaeJuncturae ossiumSkeletal ArticulationsSkeletal JunctionsSynarthrosesSynarthrosisSyndesmologiaSyndesmologySynosteologySynovial JointsSystema articulare

Synopsis

Joints: Anatomy, Physiology, Health Assessment, and Nutritional Support

1. Definition and Overview

A joint is any place in the body where two bones meet. Joints are part of the skeletal system. More precisely, joints — or articulations — are sites where two or more bones meet, and they play a crucial role in providing the skeleton with mobility and holding the skeleton together. The adult human body has 206 bones, and with the exception of the hyoid bone in the neck, each bone is connected to at least one other bone.

Joint stability and movement are interrelated: stable joints allow for little or no mobility between the adjacent bones, while joints that provide the most movement between bones are the least stable. Understanding the relationship between joint structure and function helps to explain why particular types of joints are found in certain areas of the body.

2. Classification of Joints

2.1 Structural Classification

The structural classification of joints is based on whether the articulating surfaces of the adjacent bones are directly connected by fibrous connective tissue or cartilage, or whether the articulating surfaces contact each other within a fluid-filled joint cavity. These differences divide the joints of the body into three structural classifications.

Fibrous Joints: At a fibrous joint, the adjacent bones are united by fibrous connective tissue. Bones are joined by dense fibrous connective tissue; no joint cavity is present; most are immovable. Fibrous joints usually contain a lot of collagen. There are three types: sutures, which hold the plates of the skull together; gomphoses, which hold teeth in place in the jaw bones; and syndesmoses, which hold two closely related bones together — for example, keeping the tibia connected to the fibula.
Cartilaginous Joints: At a cartilaginous joint, the bones are joined by hyaline cartilage or fibrocartilage. Cartilaginous joints are cushioned by a layer of cartilage that joins the bones together. Most cartilaginous joints have some movement, but do not move far or in many directions. A notable example is the intervertebral disc: the intervertebral symphysis fills the gap between adjacent vertebrae and provides cushioning during high-impact activity.
Synovial Joints: At a synovial joint, the articulating surfaces of the bones are not directly connected but instead come into contact within a joint cavity filled with lubricating fluid. Synovial joints allow for free movement between the bones and are the most common joints of the body.

2.2 Functional Classification

Functional classification is based on the amount of movement the joint permits. The three functional joint types include the immovable synarthrosis, slightly moveable amphiarthrosis, and freely moveable diarthrosis. The two classification schemes correlate: synarthroses are fibrous, amphiarthroses are cartilaginous, and diarthroses are synovial.

Synarthroses (immovable): The immobile nature of these joints provides for a strong union between the articulating bones. This is important at locations where the bones provide protection for internal organs.
Amphiarthroses (slightly movable): An amphiarthrosis is a joint that has limited mobility. An example is the cartilaginous joint that unites the bodies of adjacent vertebrae.
Diarthroses (freely movable): A freely mobile joint is classified as a diarthrosis. This functional classification describes all synovial joints of the body, which provide the majority of body movements. Most diarthrotic joints are found in the appendicular skeleton and give the limbs a wide range of motion.

2.3 Subtypes of Diarthrotic (Synovial) Joints by Axes of Motion

Diarthroses are classified as uniaxial (for movement in one plane), biaxial (for movement in two planes), or multiaxial joints (for movement in all three anatomical planes).

Uniaxial: A uniaxial diarthrosis, such as the elbow, is a joint that only allows for movement within a single anatomical plane.
Biaxial: Joints that allow for movements in two planes are biaxial, such as the metacarpophalangeal joints of the fingers.
Multiaxial: A multiaxial joint, such as the shoulder or hip joint, allows for three planes of motions.

3. Structure and Components of Synovial Joints

A synovial joint consists of three primary components: the articular capsule, articular cartilage, and synovial fluid. These structures work together to facilitate movement, reduce friction, and provide lubrication within the joint.

3.1 Articular Capsule

The articular capsule surrounds the joint and is continuous with the periosteum of the articulating bones. It is composed of two distinct layers:

Fibrous layer (outer): Consists of white fibrous tissue, known as the capsular ligament. It holds together the articulating bones and supports the underlying synovium.
Synovial layer (inner): A highly vascularised layer of serous connective tissue. It absorbs and secretes synovial fluid and is responsible for the mediation of nutrient exchange between blood and joint. Also known as the synovium.

3.2 Articular Cartilage

At synovial joints, the articular surfaces of bones are covered with smooth articular cartilage. This gives the bones of a synovial joint the ability to move smoothly against each other, allowing for increased joint mobility. The articular cartilage has two main roles: minimising friction upon joint movement, and absorbing shock. Articular cartilage is relatively avascular and is reliant upon the passive diffusion of nutrients from the synovial fluid.

3.3 Synovial Fluid

Lining the inner surface of the articular capsule is a thin synovial membrane. The cells of this membrane secrete synovial fluid, a thick, slimy fluid that provides lubrication to further reduce friction between the bones of the joint. The synovial fluid of natural joints normally functions as a biological lubricant as well as a biochemical pool through which nutrients and regulatory cytokines traverse. It contains molecules that provide low-friction and low-wear properties to articulating cartilage surfaces.

Inside the synovial membrane, type B synoviocytes (fibroblast-like cell lines) are localized. Their primary function is to continuously extrude high-molar-mass hyaluronans into the synovial fluid. Synovial fluid is essentially an ultrafiltrate of plasma with the exception of the hyaluronan secreted by the synovium. It is normally highly viscous due to its hyaluronan content and plays a crucial role in maintaining healthy cartilage and protecting the joint surface.

3.4 Ligaments, Bursae, and Other Accessory Structures

Ligaments support the joint by holding the bones together and resisting excess or abnormal joint motions. Additional factors that contribute to joint stability include ligaments, muscle tone, and joint shape, providing a framework for understanding how movement and support are balanced.

Bursae are flattened, fibrous sacs lined with synovial membrane and containing synovial fluid, found where ligaments, muscles, skin, tendons, or bones interact. These structures reduce friction in synovial joints.

In some synovial joints, the joint may be divided, completely or incompletely, by an articular disk or meniscus, the periphery of which is continuous with the fibrous capsule while its free surfaces are covered by synovial membrane.

3.5 Damage Response

The joint's damage response is synovial fluid production, leading to swelling and inflammation that stretches the highly innervated articular capsule and causes joint pain and stiffness. Compression of the underlying bone also results in pain, as bones are richly innervated.

4. Physiological Functions of the Joint System

The joint system serves several integrated physiological functions:

Enabling movement: These joints allow the muscles of the body to pull on a bone and thereby produce movement of that body region. The ability to kick a soccer ball, pick up a fork, and dance depends on mobility at these types of joints.
Structural support and protection: Most of the joints of the skull are held together by fibrous connective tissue and do not allow for movement between the adjacent bones. This lack of mobility is important because the skull bones serve to protect the brain. Similarly, other joints united by fibrous connective tissue allow for very little movement, which provides stability and weight-bearing support for the body.
Shock absorption and load distribution: The thick fibrocartilage pad of the intervertebral disc fills the gap between adjacent vertebrae and provides cushioning during high-impact activity.
Integrated segmental mobility: The joints of the vertebral column only allow for small movements between adjacent vertebrae, but when added together, these movements provide the flexibility that allows the body to twist, or bend to the front, back, or side.
Lubrication and nutrient delivery: Within the articular cartilage, hyaluronan provides viscoelastic properties allowing ease of motion between opposing surfaces and increasing compressive resistance. Within the synovium, hyaluronic acid as a component of synovial fluid provides an effective barrier regulating the introduction of plasma components.

5. Joint Movements

Synovial joints permit a range of named movements. These include:

Abduction (movement away from the midline), adduction (movement toward the midline), circumduction (circular movement combining flexion, extension, abduction, and adduction), and rotation (turning of a bone around its own long axis, e.g., rotation of the head, humerus, or femur).
Supination/pronation (rotation of the forearm), dorsiflexion/plantarflexion (upward/downward movement of the foot), inversion/eversion (sole of foot turns medially/laterally), and protraction/retraction (anterior/posterior movement, e.g., jaw).

6. Assessment of Joint Health

6.1 Clinical and Physical Examination

A thorough history and physical exam — with a focused musculoskeletal exam — should be performed on all patients. Typical exam findings in osteoarthritis include bony enlargement, crepitus, effusions (non-inflammatory), and a limited range of motion. Tenderness may be present at joint lines, and there may be pain upon passive motion.

Classic physical exam findings in hand osteoarthritis include Heberden's nodes (posterolateral swellings of distal interphalangeal joints), Bouchard's nodes (posterolateral swellings of PIP joints), and "squaring" at the base of the thumb (first carpometacarpal joints).

Knee osteoarthritis usually presents with a typical symptomatic triad including: gradual onset of pain that worsens with activity and abates with rest; stiffness in the morning or following daytime inactivity; and limited range of motion and function restriction. Evaluation of standing alignment and gait is essential to reveal static varus–valgus malalignment or dynamic knee instability.

6.2 Imaging Modalities

There is no single test for osteoarthritis. Characterized by degenerative changes in the bones, cartilage, menisci, ligaments, and synovial tissue, OA has evolved to be considered a disease of the whole joint. Traditionally diagnosed with radiographs demonstrating joint space width and osteophytes, additional modalities such as MRI, ultrasound, and optical coherence tomography have enhanced OA diagnosis and management through improvements in soft tissue depiction.

X-ray: X-rays can show loss of joint space, bone damage, bone remodeling, and bone spurs. Early joint damage does not usually appear on X-rays.
MRI: MRI can show damage to soft tissues in and around the joint. Generally, MRI helps health care providers evaluate a joint that is locking or giving out.
Blood and fluid tests: Blood tests are used to rule out other causes for symptoms. Joint fluid samples may be taken to look for other causes of joint pain, such as infection or gout.

6.3 Factors Supporting Normal Joint Function

Non-pharmacological strategies are foundational to joint health. Knee osteoarthritis management can be performed in community and primary care, with the objective of reducing pain, improving physical function, diminishing disability, and improving quality of life. Initial treatment begins with conservative methods, including pharmacological and nonpharmacological therapies such as exercise and weight loss.

Risk factors for developing osteoarthritis include age, female gender, obesity, anatomical factors, muscle weakness, and joint injury (from occupation or sports activities). Consequently, maintaining healthy body weight, engaging in regular physical activity, and avoiding excessive mechanical loading are recognized strategies for supporting normal joint function.

7. Common Conditions and Disorders of the Joint System

More than 100 different types of arthritis have been described, the most common being osteoarthritis or degenerative arthritis, which is non-inflammatory arthritis. Inflammatory arthritis can occur in several settings, with inflammation caused by autoimmune processes (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis), crystal deposition-induced inflammation (gout, pseudogout, basic calcium phosphate disease), or infections (septic arthritis, Lyme arthritis).

7.1 Osteoarthritis (OA)

Osteoarthritis is the most common form of arthritis in the world. It can be classified into two categories: primary osteoarthritis and secondary osteoarthritis. Classically, OA presents with joint pain and loss of function; however, the disease is clinically very variable and can present merely as an asymptomatic incidental finding or as a devastating, permanently disabling disorder.

Osteoarthritis occurs due to degeneration of the cartilage and tissues in the joint, primarily due to aging, joint injury or overuse, and obesity. OA, especially of the knee joint, continues to increase worldwide, affecting an estimated 528 million people in 2019. In addition, 73% of these individuals are 55 years or older, and the knee tends to be the most frequently affected joint.

In osteoarthritis, the major contributory factors include advancing age, female sex, joint trauma, and obesity. Some genetic factors have been described, such as mutations in genes encoding types II, IV, V, and VI collagens.

7.2 Rheumatoid Arthritis (RA)

Rheumatoid arthritis (RA) is an autoimmune systemic inflammatory disorder. RA is one of the most common symmetric, peripheral polyarthritis chronic inflammatory rheumatic diseases of unknown etiology. The general prevalence of RA is about 0.5% to 1% in the adult population, with a male-to-female prevalence ratio of 1:3.

7.3 Gout

In gout, prolonged hyperuricemia leads to uric acid deposition in joints, which then leads to joint inflammation. Male sex, advancing age, chronic kidney disease, alcoholism, and certain drugs such as diuretics are additional risk factors for hyperuricemia and gout. In a 2013 study analyzing data from national surveys, the number of ambulatory care visits attributable to gout was estimated to be 7 million annually, with 2 million attributable to acute attacks — and this rate more than doubled from 2002 to 2008.

7.4 Other Joint Conditions

Psoriatic arthritis and ankylosing spondylitis: These are autoimmune-process inflammatory arthritides affecting multiple joints and, in the case of ankylosing spondylitis, the axial skeleton.
Septic arthritis: Septic arthritis is acute arthritis that is rare in the general population, but patients with pre-existing risk factors such as immunodeficiency, advancing age, diabetes mellitus, prosthetic joints, rheumatoid arthritis, and intravenous drug abuse are at higher risk.
Bursitis and ligament sprains: Sprains involve ligaments that are stretched or torn, common in ankle, knee, and lumbar spine; they heal slowly due to poor blood supply.

8. Nutrients, Herbs, and Natural Ingredients Used to Support Joint Health

The following subsections distinguish between traditional use and scientific evidence for each key ingredient. Evidence quality is characterized explicitly.

8.1 Glucosamine and Chondroitin

Traditional and Historical Use

Glucosamine and chondroitin are naturally occurring compounds found in cartilage and connective tissue. They were not prominently used in traditional herbal medicine systems; their emergence as supplements for joint health developed from mid-twentieth century biochemical research identifying their roles in proteoglycan and cartilage matrix synthesis.

Scientific Evidence

A 2025 systematic review screened 2,013 articles and included 146 studies, with nearly 60% being randomized controlled trials conducted in Europe, Asia, or the U.S. Most studies focused on osteoarthritis and joint pain, with over 90% of efficacy studies reporting positive outcomes and most safety studies indicating minimal or no adverse effects. Glucosamine and chondroitin were most commonly administered together at daily doses of 1,500 mg and 1,200 mg respectively, and often compared to placebo or celecoxib.

The overall evidence suggests that glucosamine and chondroitin are generally effective and well-tolerated, particularly for managing osteoarthritis and joint pain. Consistent dosing strategies and favorable safety profiles support their continued use in clinical practice, but further research is needed related to other disease states.

However, conclusions across studies are not uniform. Some systematic reviews reported inconsistent conclusions with only modest effects on reported pain and function. A reduction in joint space narrowing was more consistently observed, but the effect size was small and the clinical significance uncertain. A separate review of eight primary trials of more than 12 months' duration showed evidence of statistically significant improvements in joint space loss, pain, and function for glucosamine sulfate, although clinical importance was not clear. In two studies of glucosamine sulfate, the need for knee arthroplasty was reduced from 14.5% to 6.3% at 8 years' follow-up.

Notably, a Cochrane review of 25 clinical studies involving 4,963 patients found that glucosamine failed to show any benefit and its effect on pain was as good as that of a placebo. The American College of Rheumatology and the Arthritis Foundation both prescribe chondroitin sulfate for OA in accordance with 2019 therapy guidelines. Overall, the body of evidence is mixed; effect sizes are generally modest, and study quality varies considerably.

8.2 Curcumin (Turmeric, Curcuma longa)

Traditional Use

Curcumin is the active compound in turmeric, the bright yellow spice common in Indian cuisine. It has been used for centuries in Ayurvedic medicine for its potent anti-inflammatory and antioxidant properties. In traditional Ayurvedic practice, turmeric root was prepared as a paste, decoction, or mixed into warm milk and used to address inflammation, pain, and swelling of the joints.

Scientific Evidence

Meta-analyses of eight randomized controlled trials (RCTs), with more than 800 participants with primarily knee OA, found scientific evidence supporting the efficacy of turmeric extract (approximately 1,000 mg/day of curcumin) in treating OA. Curcumin may have some beneficial effects on knee pain and quality of life in patients with knee OA. Although curcumin is less effective at relieving pain than ibuprofen, it appears safe for short-term use and may reduce the need for rescue medication.

A key limitation is bioavailability: a challenge in curcumin research is its bioavailability. Standard curcumin has very poor absorption unless formulated with enhancers such as piperine (black pepper extract) or lipid delivery systems. Studies have failed to demonstrate a dramatic reduction in OA symptoms by curcumin but have suggested strategies by which curcumin might be effective in OA. Overall, the evidence for curcumin in joint health is preliminary to moderate: positive signals exist in RCTs for pain reduction, but effect sizes are modest and bioavailability confounds generalizability.

8.3 Boswellia (Boswellia serrata)

Traditional Use

Boswellia serrata is a branching tree native to the mountainous regions of Northern Africa, India, and the Middle East. Boswellic acids are derived from the resin of Boswellia plants and have a long history of use in treating inflammatory diseases. In Ayurvedic medicine, the resin of Boswellia (known as shallaki) was traditionally prepared as a paste or decoction for joint conditions, including conditions resembling rheumatoid arthritis.

Scientific Evidence

Among boswellic acids, 3-acetyl-11-keto-β-boswellic acid (AKBBA) has been found to be a potent inhibitor of leukotriene-mediated inflammatory pathways and 5-lipoxygenase (5-LO) activities. It has been shown to inhibit inflammatory mediators, matrix metalloproteins, and other adhesion factors in in vitro studies.

A meta-analysis including seven clinical trials involving 545 patients reported that Boswellia and its extracts had a positive effect on relieving pain and stiffness and improving joint function.

A 2024 randomized, double-blind, placebo-controlled trial tested a standardized extract of B. serrata at 150 mg or 300 mg twice daily for 90 days in 105 participants with knee OA. The trial was conducted to understand its safety and efficacy in supporting joint health and improving mobility and symptoms of OA of the knee. Boswellia has been shown to suppress inflammatory mediators and ameliorate synovitis.

A 2025 randomized, double-blind, multicenter, placebo-controlled clinical trial of Boswellia in combination with celery extract found that oral administration of the nutraceutical resulted in prolonged symptomatic relief with reduced pain, stiffness, and swelling. Inflammatory biomarkers (serum IL-7, IL-1, IL-6, hs-CRP, TNF-α, ESR) and cartilage degeneration biomarkers (serum CTX-II, COMP, MMP-3 and urinary CTX-II) were decreased in the nutraceutical group compared to baseline and placebo. Serum levels of collagen synthesis markers were increased, suggesting collagen synthesis contributing to cartilage regeneration. At the given doses for 90 days, there were no adverse effects.

The evidence for Boswellia is moderate and more consistent than for some other botanicals, particularly for short-term symptom relief in knee OA, but long-term data remain limited.

8.4 Omega-3 Polyunsaturated Fatty Acids (Fish Oil)

Traditional Use

Omega-3 fatty acids from marine sources have been part of the traditional diets of coastal and Arctic populations for centuries. Fish liver oils were historically used in Northern European folk medicine for musculoskeletal complaints and inflammatory conditions, predating the isolation of specific active compounds.

Scientific Evidence

Many clinical trials of omega-3 fatty acids, supplied as fish oil supplements, have been carried out in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and osteoarthritis over the past three decades. A total of 20 clinical trials have been carried out in RA, of which 16 exhibited significant improvements in multiple disease clinical outcomes.

In a meta-analysis of ten RCTs involving 183 RA patients and 187 placebo-treated RA controls, omega-3 PUFAs clearly reduced nonsteroidal anti-inflammatory drug (NSAID) consumption (SMD −0.518, 95% CI −0.915 to −0.121, p = 0.011) without between-study heterogeneity.

A meta-analysis of 18 RCTs with 1,018 RA patients found that omega-3 supplementation increased EPA and DHA but reduced the omega-6:omega-3 ratio in RA patients.

For osteoarthritis, nine RCTs with 2,070 patients with OA contributed to a meta-analysis. Pooled results showed that omega-3 PUFA supplementation could significantly relieve arthritis pain compared to placebo (SMD: −0.29, 95% CI −0.47 to −0.11, p = 0.002), though with moderate heterogeneity (I² = 60%).

Multiple mechanisms for the clinical effects of omega-3 fatty acids have been implicated, including the modulation of eicosanoid synthesis toward a more anti-inflammatory profile and suppressed production of proinflammatory cytokines. Overall, fish oil supplements appear to be a safe and effective agent that could be added to current treatment regimens in RA. Evidence is stronger for RA than for OA; the OA evidence, while positive, is of moderate strength with meaningful heterogeneity.

8.5 Collagen (Undenatured Type II Collagen)

Traditional Use

Collagen-rich broths prepared from animal cartilage, bones, and tendons have been consumed for joint and bone complaints across numerous traditional cultures globally, including Chinese, European, and Indigenous culinary traditions. This was largely empirical practice rather than a codified medicinal tradition.

Scientific Evidence

Collagen and eggshell membrane contribute to cartilage repair and maintenance. Collagen, omega-3 fatty acids, vitamins, and various plant-derived products have been studied clinically in the context of osteoarthritic pathogenic processes. However, results are variable, and their efficacy and safety are controversial. Clinical evidence through meta-analysis studies shows limited benefits through symptomatic relief, with marginal and inconsistent outcomes. The evidence for collagen supplementation in human joint health remains preliminary, and high-quality head-to-head trials are lacking.

8.6 Methylsulfonylmethane (MSM)

Traditional Use

MSM is an organosulfur compound that does not have a strong presence in traditional herbal medicine. Its use as a supplement for joint health emerged primarily in the latter half of the twentieth century following research into the role of sulfur in connective tissue biology.

Scientific Evidence

Glucosamine and chondroitin sulfate, MSM, collagen, omega-3 fatty acids, vitamins, and various plant-derived products have been studied clinically and shown to have effects in osteoarthritic pathogenic processes. Evidence for MSM as a standalone intervention in joint health is limited: it has been tested in a small number of RCTs for knee OA with some positive signals for pain reduction, but studies are generally short-term and underpowered, and it is frequently tested in combination with glucosamine or chondroitin, making isolation of its individual effects difficult.

8.7 Hyaluronic Acid

Traditional Use

Hyaluronic acid does not feature in traditional herbal medicine. Its use in joint care emerged from twentieth-century biochemistry identifying it as a key component of synovial fluid and articular cartilage.

Scientific Evidence

Hyaluronic acid is an integral part of both synovial fluid and articular cartilage. Within the articular cartilage, it provides viscoelastic properties allowing ease of motion between opposing surfaces and increasing compressive resistance. Intra-articular injections of hyaluronic acid are a clinically established intervention for knee OA, though oral supplementation is less well-characterized in the literature and evidence remains preliminary.

8.8 Vitamin D

Traditional Use

Historically, foods rich in fat-soluble vitamins (such as cod liver oil and fatty fish) were used in Northern European traditions for conditions resembling rickets and joint weakness, without knowledge of the specific vitamin involved.

Scientific Evidence

Vitamin D is believed to play a role in bone health and immune regulation. Vitamin D deficiency has been associated with increased risk of musculoskeletal pain and accelerated cartilage loss in some observational studies; however, interventional RCT evidence for vitamin D supplementation specifically improving joint outcomes is mixed, and current evidence does not firmly establish a therapeutic role independent of correcting deficiency.

8.9 Summary Table: Evidence Strength for Key Ingredients

Glucosamine/Chondroitin: Moderate, mixed evidence. Positive signals for OA pain and joint space narrowing; Cochrane review finds effects comparable to placebo in some analyses. Dosing typically 1,500 mg/1,200 mg daily.
Curcumin (Turmeric): Preliminary to moderate evidence. RCTs show pain reduction in knee OA; effect size modest; significantly constrained by poor bioavailability.
Boswellia serrata: Moderate evidence. Meta-analysis of 7 trials (n=545) shows positive effects on pain and stiffness; newer RCTs also show anti-inflammatory biomarker improvements.
Omega-3 Fatty Acids: Moderate to good evidence for RA (NSAID-sparing effect, symptom improvement); moderate evidence for OA (statistically significant pain reduction in meta-analysis). Evidence is stronger for RA.
Type II Collagen: Preliminary. Some RCTs show benefit; evidence base is smaller and more heterogeneous.
MSM: Preliminary. Small RCTs show some pain reduction in knee OA; evidence insufficient to draw firm conclusions.
Hyaluronic Acid (oral): Preliminary for oral supplementation. Intra-articular injection has a stronger evidence base.
Vitamin D: Mixed. Role in bone health established; specific joint/cartilage benefit from supplementation not firmly established.

References

Natural Remedies

Remedy 1

Turmeric & Black Pepper Golden Milk: Turmeric contains curcumin, a compound with potent anti-inflammatory and antioxidant properties that can help reduce joint pain and swelling. Stir one teaspoon of turmeric into warm milk with a pinch of black pepper and a drizzle of a healthy fat like coconut oil — the black pepper and fat significantly enhance curcumin absorption. Drink daily for at least 4–8 weeks to gauge benefits.

Remedy 2

Omega-3-Rich Anti-Inflammatory Diet: Omega-3 fatty acids (EPA and DHA) help reduce the production of inflammatory chemicals like prostaglandins and cytokines that contribute to joint pain and stiffness. Aim for 2–3 servings per week of fatty fish such as salmon, mackerel, or sardines, and supplement plant-based sources like walnuts, chia seeds, and flaxseeds into daily meals. This approach also supports the synovial fluid that lubricates joints.

Remedy 3

Ginger Tea or Food Supplementation: Ginger contains anti-inflammatory compounds traditionally used to ease pain and stiffness, and modern studies suggest it may help alter inflammatory markers in joint conditions. Brew fresh ginger root slices in hot water for 10 minutes to make a tea, or add grated ginger generously to stir-fries, smoothies, and soups daily. Consistent use over several weeks is recommended for noticeable joint comfort.

Remedy 4

Boswellia (Indian Frankincense) Supplement: Boswellia serrata, used for centuries in Ayurvedic medicine, contains boswellic acids that may reduce inflammation and improve physical function in conditions like osteoarthritis. It is commonly taken in capsule or extract form; look for standardized extracts and follow label directions. Several studies support its ability to improve joint pain and mobility with regular use.

Remedy 5

Low-Impact Movement (Swimming, Walking, Yoga): Regular low-impact exercise is considered one of the most effective strategies for joint health, as it keeps joints flexible, strengthens surrounding muscles, and supports healthy synovial fluid production. Activities like swimming, walking, cycling, and yoga minimize stress on cartilage while delivering meaningful cardiovascular and musculoskeletal benefits. Aim for at least 30 minutes of gentle, consistent movement most days of the week.

Remedy 6

Adequate Hydration Throughout the Day: Cartilage is made up of nearly 80% water, and this water content gives it the soft, cushioning effect needed to absorb shock and allow smooth movement — dehydration reduces this protective function. Synovial fluid, which lubricates joints, also depends on adequate hydration from the bloodstream. Sip water steadily throughout the day, aiming for at least 8 glasses, and include hydrating foods like cucumbers, watermelon, and herbal teas.

Remedy 7

Bone Broth & Collagen-Supporting Foods: Collagen is a primary protein in cartilage, ligaments, and tendons, and natural production declines with age, contributing to joint pain and stiffness. Sipping homemade bone broth regularly provides collagen-building compounds, while eating vitamin C-rich foods (citrus, berries, bell peppers) supplies the nutrient essential for the body's own collagen synthesis. Berries also deliver antioxidants that help protect joints from oxidative damage.

Remedy 8

Hot & Cold Therapy: Applying cold packs can reduce swelling and numb acute joint pain during flare-ups, while heat packs relax surrounding muscles and improve blood flow to stiff joints. Use a cold pack wrapped in a cloth for up to 20 minutes on inflamed joints, and switch to a warm compress or warm Epsom salt soak for stiffness and aching. Epsom salt baths are also valued in natural health practice for their magnesium content, which may help relax muscles around joints.

Remedy 9

Stress Reduction & Quality Sleep: Chronic stress triggers the release of cortisol, a hormone that can promote systemic inflammation and worsen joint pain, while poor sleep is linked to increased pain perception and joint stiffness. During deep sleep, the body releases growth hormone that repairs joint tissues and regenerates cells, making 7–9 hours of restful sleep a foundational joint-care practice. Incorporate stress-reduction tools such as meditation, deep breathing, gentle yoga, or time in nature to lower cortisol and support overnight joint recovery.

Remedy 10

Anti-Inflammatory Diet Pattern (Mediterranean-Style): Following a Mediterranean-style eating pattern — rich in colorful vegetables, fruits, whole grains, olive oil, nuts, and fatty fish — reduces systemic inflammation that drives joint breakdown and cartilage loss. Olive oil contains oleocanthal, a compound with natural anti-inflammatory properties, while limiting processed foods, refined sugars, and fried foods removes key dietary drivers of joint inflammation. Adopting this pattern consistently is considered one of the most evidence-backed dietary approaches for long-term joint health.

Ingredients

These ingredients are often used in alternative medicine to support joints.

ajwainScientific
Animal studies document that ajwain extract reduced inflammatory markers in arthritis-induced rats over 21 days. Thymol and carvacrol inhibit COX-mediated prostaglandin synthesis and NF-κB pathways relevant to joint inflammation. Traditional Ayurvedic and Persian medicine explicitly list rheumatoid arthritis as an indication.
ALA (alpha-linolenic acid)Scientific
ALA reduces joint inflammation by modulating eicosanoid synthesis, suppressing pro-inflammatory cytokines, and competing with arachidonic acid in COX/LOX pathways. Placebo-controlled human RCT data in RA patients and robust animal model evidence support ALA's role in joint health.
ALA (alpha-lipoic acid)Scientific
ALA has been evaluated in both osteoarthritis and rheumatoid arthritis RCTs for its anti-inflammatory effects on joint tissues. A trial in 78 OA patients showed significant reductions in joint inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-17, IL-23) and NF-κB downregulation. RA RCTs have shown mixed results.
algal oilScientific
DHA and EPA from algal oil reduce synovial inflammation in joints through suppression of pro-inflammatory cytokines and competition with arachidonic acid eicosanoid pathways. Clinical studies in rheumatoid arthritis patients show reductions in IL-1β, TNF-α, and IL-6. Omega-3 supplementation reduces joint stiffness and pain and is recommended as complementary therapy in inflammatory arthritis.
aloe veraScientific
Aloe vera has documented anti-inflammatory effects relevant to joint health, including downregulation of TNF-α, COX-2, and MMP-9 in inflammatory arthritis models. Traditional use for both osteoarthritis and rheumatoid arthritis pain is extensive, and oral aloe vera has been cited for chronic non-cancer pain including osteoarthritis.
alpinia galangalScientific
A. galanga targets joint health via COX-2 inhibition, MMP downregulation in human synovial fibroblasts, and demonstrated anti-arthritic activity in animal models. Preliminary human evidence from a quasi-experimental RA study (p<0.001) and traditional use across multiple medical systems support this relationship.
anchoviesScientific
EPA and DHA from anchovies are among the most studied dietary anti-inflammatory agents for joint conditions. They reduce synthesis of pro-inflammatory arachidonic acid eicosanoids (prostaglandin E2, leukotriene B4) implicated in joint inflammation, and their enzymatic oxidation produces resolvins and protectins that resolve inflammatory states in joint tissue.
andrographisScientific
A prospective, randomized, double-blind, placebo-controlled trial in 60 patients with active rheumatoid arthritis found that Andrographis extract (Paractin, 30% andrographolides) for 14 weeks produced significant improvements in number and grade of swollen and tender joints, HAQ score, and quality of life, alongside reduction of rheumatoid factor. Joint pain reduction, though trending toward improvement, was not statistically significant as the primary outcome.
anemarrhena asphodeloidesScientific
Sarsasapogenin from anemarrhena specifically targets synoviocyte glycolysis via PKM2 in RA models, and timosaponin AIII inhibits joint-relevant inflammatory pathways. The classical formula Guizhi Shaoyao Zhimu — named partly for anemarrhena — was developed for joint bi syndrome and is still clinically used.
annattoScientific
Tocotrienols derived from annatto have demonstrated anti-arthritic and joint-protective effects in animal models, operating through anti-inflammatory and chondrocyte self-repair mechanisms. A 2024 Frontiers in Endocrinology mini-review confirmed evidence for annatto TT in joint health across numerous animal models of osteoarthritis. Human clinical evidence for joint-specific outcomes is currently lacking.
argan nut oilScientific
An RCT of 100 knee osteoarthritis patients (30 mL/day, 8 weeks) showed significant reductions in WOMAC pain and Lequesne functional index with oral argan oil. Traditional Moroccan use for joint pain is the historical backdrop to this clinical finding.
arnicaScientific
Arnica has among its strongest clinical evidence in joint applications, with RCTs demonstrating efficacy for osteoarthritis of the knee and hand comparable to ibuprofen gel. The German Commission E approves topical arnica specifically for rheumatic joint pain. A 2024 systematic review identified multiple eligible studies for arthritis and joint inflammatory conditions.
ashwagandhaScientific
Ashwagandha (Withania somnifera) is an Ayurvedic adaptogen with anti-inflammatory withanolides studied for joint conditions. An RCT in knee OA patients (n=60, 12 weeks) found Ashwagandha root extract significantly reduced pain, stiffness, and WOMAC scores versus placebo. It inhibits NF-κB and inflammatory cytokines.
astaxanthinScientific
Astaxanthin inhibits cartilage degradation markers, NF-κB activation, and pro-inflammatory cytokines relevant to joint inflammation in preclinical models. A 2023 bone/joint review confirmed its effects on cartilage in vitro and in vivo. Human anti-inflammatory RCT data (reductions in IL-6, TNF-α, TGF-β1) provide indirect clinical support for joint benefits, but dedicated joint disease RCTs are absent.
atractylodesScientific
Atractylodes macrocephala has preclinical scientific evidence for joint-related conditions including gouty arthritis and rheumatoid arthritis, reducing joint inflammation, swelling, and uric acid deposition through NF-κB, AMPK/SIRT1, and TLR4/NLRP3 pathway modulation.
avian cartilageScientific
Avian (chicken sternal) cartilage is the source of undenatured type II collagen (UC-II), supported by multiple RCTs for knee OA. UC-II 40 mg/day was shown to be superior to glucosamine 1,500 mg + chondroitin 1,200 mg/day for improving joint pain, stiffness, and function via oral tolerization mechanism.
avocadoScientific
Avocado-soybean unsaponifiables (ASU), combining avocado and soybean oils, have the strongest evidence among plant-based joint supplements. A Cochrane review (PMC4494689) found moderate-quality evidence that ASU probably improves OA pain and function. Avocado phytosterols and fatty alcohols are the key joint-active fractions.
bacillus coagulansScientific
Clinical RCT evidence in RA patients (n=45) shows B. coagulans GBI-30, 6086 as adjunct to standard therapy improved pain, CRP, patient global assessment, and functional capacity including walking and reaching. Reduction in systemic inflammatory markers relevant to joint health is documented across multiple trials.
baikal skullcapScientific
S. baicalensis flavonoids demonstrate anti-arthritic effects via suppression of synovial inflammation. A human clinical trial using an S. baicalensis/Acacia catechu combination showed short-term symptomatic relief in knee osteoarthritis patients. Preclinical anti-inflammatory mechanisms directly relevant to joint pathology are well characterized.
barberryScientific
Barberry and berberine have scientific evidence for anti-inflammatory and immunomodulatory effects in joint diseases, particularly rheumatoid arthritis, with studies showing reduced synovial inflammation and anti-inflammatory cytokine changes. Berbamine also has documented anti-arthritic properties.
barrenwortScientific
Icariin has been studied for both osteoarthritis and rheumatoid arthritis, with chondroprotective, anti-inflammatory, and cartilage matrix-preserving effects documented in preclinical models. The 2025 Frontiers in Pharmacology review specifically confirmed ICA's therapeutic potential in bone and joint diseases. Traditional TCM use for joint pain and arthritis is extensively documented.
beef proteinScientific
Bovine collagen peptides have demonstrated significant reductions in joint pain and improvements in joint function in RCTs in both osteoarthritic and physically active populations. Collagen accumulates in cartilage and supports joint structural integrity.
berberineScientific
Berberine is an isoquinoline alkaloid from Phellodendron, Berberis, and Coptis species with anti-inflammatory activity relevant to joint health. In vitro studies show it reduces IL-1β-induced MMP and prostaglandin production in chondrocytes. Small clinical trials in OA show joint pain and biomarker reductions.
black pepperScientific
Piperine inhibited IL-6, MMP13, COX-2, and PGE2 in human rheumatoid arthritis synoviocytes in vitro. In rat arthritis models it significantly reduced paw edema and joint inflammation histologically. These represent the closest-to-human joint evidence available for piperine.
blackboard treeScientific
Anti-arthritic activity of A. scholaris leaf extract has been demonstrated in preclinical arthritis models, with significant reductions in WBC count and erythrocyte sedimentation rate. Topical latex and bark paste applications for rheumatic joint pain are traditional practices across Ayurveda and folk medicine.
blueberryScientific
Blueberry anthocyanins suppress NF-κB and reduce pro-inflammatory cytokines (TNF-α, IL-6, CRP) that drive joint inflammation and cartilage degradation. Human RCT evidence for blueberry specifically in arthritis is limited but supported by anti-inflammatory mechanistic data.
borageScientific
The joints are the best-evidenced body system target for borage seed oil, supported by multiple RCTs, a Cochrane systematic review, and endorsement from Versus Arthritis (UK). GLA-derived DGLA reduces synovial inflammation via leukotriene and cytokine suppression, with clinical trials demonstrating significant reductions in tender joint count, swelling, and disease activity in RA.
borage oilScientific
Borage oil has the most robust clinical evidence of any herbal supplement for joint health, specifically in rheumatoid arthritis. Multiple RCTs and a Cochrane review demonstrate significant reductions in joint tenderness, swelling, morning stiffness, and disease activity, with NSAID-sparing effects.
boronScientific
Boron is a trace mineral with proposed roles in joint health, particularly in relation to bone and cartilage metabolism. Epidemiological data show lower arthritis rates in regions with higher soil boron, and small clinical trials report reduced OA symptoms with boron supplementation (3–6 mg/day). It influences calcium, magnesium, and vitamin D metabolism.
boswelliaScientific
Boswellia serrata resin extracts, especially AKBA (acetyl-11-keto-β-boswellic acid), are among the best-studied herbal interventions for joint health. Multiple RCTs and a systematic review/meta-analysis demonstrate significant improvements in knee OA pain, stiffness, and function. A 2025 network meta-analysis ranked Boswellia as the most effective nutritional supplement for knee OA pain.
boswellic acidScientific
Boswellic acids are the active constituents of Boswellia serrata resin, with AKBA being the most potent. They selectively inhibit 5-LOX, reducing leukotriene-driven joint inflammation. RCT and meta-analysis data support clinically meaningful reductions in knee OA pain and improved function.
bovine cartilageScientific
Bovine cartilage provides chondroitin sulfate and other glycosaminoglycans used clinically for joint support. Bovine-derived chondroitin sulfate has been studied in OA RCTs with evidence for pain reduction. Glycosaminoglycans from bovine cartilage support synovial fluid viscosity and cartilage matrix integrity.
bromelainScientific
Bromelain is a proteolytic enzyme complex from pineapple (Ananas comosus) stem with established anti-inflammatory properties relevant to joint health. Clinical trials show it reduces joint pain and swelling in OA and rheumatoid arthritis. German Commission E and ESCOP recognize bromelain's anti-edematous and analgesic properties.
burdockScientific
A human RCT (Maghsoumi-Norouzabad et al., Int J Rheum Dis, 2016) in knee osteoarthritis patients demonstrated significant reduction of joint-related inflammatory markers (IL-6, hs-CRP) after 6 weeks of daily burdock root tea. A companion clinical study confirmed improved lipid profile and blood pressure in the same joint-disease population. Preclinical studies confirm anti-inflammatory and antinociceptive effects relevant to joint conditions.
cabbageScientific
Topical cabbage leaf wraps have been tested in multiple RCTs for knee osteoarthritis, demonstrating significant pain reduction and improved function. Oral cabbage phytochemicals (sulforaphane, anthocyanins) have preclinical evidence for cartilage protection and joint inflammation reduction. The Arthritis Foundation recommends anthocyanin-rich vegetables like red cabbage as part of an arthritis dietary regimen.
cabbage leafScientific
Joints—particularly the knee—are the primary musculoskeletal site with RCT-level clinical evidence for topical cabbage leaf application. Two randomized controlled trials (Lauche et al. 2016; Chobpenthai et al. 2022, PMC9200597) demonstrated that cabbage leaf wraps applied daily for 4 weeks significantly reduce pain, functional disability, and improve quality of life in knee osteoarthritis patients. Traditional European use for arthritic and rheumatic joint swellings parallels and predates the clinical evidence.
calamari oilScientific
DHA and EPA from calamari oil reduce joint inflammation via anti-inflammatory mechanisms, with clinical and preclinical evidence supporting use in rheumatoid arthritis and inflammatory arthritis. A 2022 meta-analysis found omega-3 consumption improved symptoms of inflammatory rheumatic diseases. Typical clinical doses are 2–4 g/day combined EPA+DHA.
campesterolScientific
Campesterol has demonstrated anti-inflammatory and analgesic effects in joint tissue in CFA-induced arthritis animal models, reducing paw edema, cytokine-driven synovial inflammation, and joint hypersensitivity. The mechanism involves modulation of TNF-α, IL-1β, and IL-6 in the synovial membrane. Evidence is preclinical.
camphor oilScientific
Camphor oil is widely used topically for joint pain in arthritis, rheumatism, and sprains. Its analgesic (TRPV1/TRPA1 modulation) and anti-inflammatory mechanisms have been characterized in peer-reviewed research. The PMC 2025 review documents camphor's historical prescription for arthritis and joint inflammation across multiple medical traditions.
capsaicinoidsScientific
Topical capsaicin is among the most clinically validated natural treatments for joint pain. Multiple RCTs in osteoarthritis and rheumatoid arthritis, a 2024 systematic review/meta-analysis, and a 2018 network meta-analysis all confirm significant analgesic benefit for peripheral joint conditions.
capsicumScientific
Capsaicin has well-documented clinical efficacy for joint pain in both osteoarthritis and rheumatoid arthritis, with multiple RCTs supporting topical application and inflammatory mediator reductions in synovial fluid. Capsaicin-containing products are standard OTC joint pain treatments.
caryophylleneScientific
BCP consistently reduces joint inflammation, cartilage-damaging enzyme expression, and pain in osteoarthritis and collagen antibody-induced arthritis models. Human chondrocyte in vitro data are available.
cat's clawScientific
Cat's Claw (Uncaria tomentosa) is a Peruvian vine used traditionally by Amazonian peoples for joint inflammation and arthritis. A double-blind RCT found Cat's Claw extract significantly reduced pain and swelling in knee OA over 4 weeks. Active oxindole and pentacyclic alkaloids modulate TNF-α and NF-κB pathways.
catechinsScientific
Catechins—primarily EGCG—reduce joint inflammation by inhibiting NF-κB and MMP expression in synovial tissue, which are key mediators of cartilage degradation in arthritis. Preclinical evidence is strong; human evidence is primarily from inflammatory biomarker studies in metabolic and inflammatory conditions.
cayenne pepperScientific
Topical capsaicin is among the most evidence-backed natural interventions for joint pain across multiple joint conditions including osteoarthritis and rheumatoid arthritis. Multiple RCTs, a positive meta-analysis (Phytotherapy Research, 2024), and Cochrane-reviewed data support efficacy via substance P depletion at joint nociceptors.
centella triterpenesScientific
Centella triterpenes (asiaticoside, asiatic acid, madecassoside, madecassic acid) are the key bioactives of Centella asiatica. They stimulate collagen and proteoglycan synthesis and inhibit MMP activity. In vitro and animal evidence supports their role in connective tissue repair relevant to joint health.
cetylated fatty acidsScientific
Cetylated fatty acids (CFA), including cetyl myristoleate and related esters, have been evaluated in RCTs for knee OA. A 2025 randomized, double-blind, placebo-controlled trial (n=60, 60 days) demonstrated significant VAS pain reduction (−1.7 cm vs −0.6 cm for placebo). An earlier RCT found CFA comparable to meloxicam for knee OA.
chaff flowerScientific
Preclinical anti-arthritic activity of A. aspera is documented in Gokhale et al. (2002) and corroborated across multiple pharmacological reviews. The plant is used traditionally for joint pain and rheumatism.
cherryScientific
Tart cherry is clinically studied for both osteoarthritis and gout, the two most common forms of joint disease. Evidence for uric acid reduction and gout flare prevention is strong. OA evidence shows CRP reductions; pain symptom effects are inconsistent across trials. Traditional use for joint pain relief is well-documented.
chicoryScientific
Chicory root extract has been evaluated in a pilot clinical trial for osteoarthritis of the hip and knee, showing limited efficacy at 1,800 mg/day on WOMAC scores. Traditional use for joint-related conditions including rheumatism, arthritis, and gout is well documented across European, Indian, and Middle Eastern herbal medicine systems. Anti-inflammatory sesquiterpene lactones provide a mechanistic basis.
chinese salvia rootScientific
Danshen's anti-inflammatory, anti-osteoclastic, and angiogenesis-modulating properties are relevant to joint diseases including osteoarthritis and rheumatoid arthritis. Traditional use for rheumatism and arthralgia is long-standing. Preclinical studies show synovial inflammation reduction and cartilage protection.
chondroitinScientific
Chondroitin sulfate is a major structural component of articular cartilage extracellular matrix. Clinical trials and meta-analyses show it reduces OA pain, improves joint function, and may slow joint-space narrowing. It is recommended by EULAR for knee OA. Standard dose is 800–1,200 mg/day.
chrysinScientific
Chrysin reduces joint inflammation and damage in animal models of both rheumatoid arthritis (CFA-induced) and osteoarthritis (knee OA). Effects include reduced synovitis, cartilage erosion, bone erosion, pannus formation, and pain-related nociceptive signaling via NLRP3 inflammasome attenuation and NF-κB inhibition.
chymotrypsinScientific
Trypsin:chymotrypsin has been used clinically to reduce joint swelling, stiffness, and post-operative edema in orthopedic settings. One RCT specifically noted improved joint mobility in orthopedic surgery patients receiving trypsin:chymotrypsin. Oral proteolytic enzyme combinations including chymotrypsin have also been studied in osteoarthritis of the knee and hip.
cinnamonScientific
Cinnamon supplementation reduces inflammatory markers CRP and TNF-α in patients with rheumatoid arthritis in a clinical RCT, and has traditional use for rheumatism and joint pain. Mechanistically, cinnamaldehyde inhibits NF-κB and COX pathways central to joint inflammation.
cissus quadrangularisScientific
Cissus quadrangularis (veldt grape) is an Ayurvedic medicinal plant traditionally used for bone and joint healing. Several animal studies and small human RCTs suggest it reduces joint pain and improves mobility in OA and exercise-induced joint damage. Active phytosterols and ketosteroids are proposed as key joint-active constituents.
CLA (conjugated linoleic acid)Scientific
CLA has been studied in joint-related inflammatory conditions, primarily rheumatoid arthritis. Clinical evidence shows that CLA supplementation—especially combined with vitamin E—can reduce morning stiffness, joint pain, and inflammatory markers in RA patients. CLA inhibits COX-2 and TNF-α, key drivers of joint inflammation.
clematisScientific
Joints are the primary therapeutic target for Clematis in both TCM and evidence-based research. Multiple randomized controlled trials using SKI306X (C. mandshurica) demonstrate pain reduction and cartilage protection in knee osteoarthritis and rheumatoid arthritis patients. Wei Ling Xian has been used for joint pain in TCM for over 1,000 years.
cloveScientific
Eugenol's COX-2 inhibition, NF-κB suppression, and uric acid-lowering properties are directly relevant to joint inflammation. Animal studies confirm arthritic joint suppression, and pharmacological reviews document rheumatoid arthritis and joint pain as indications for eugenol.
cod liver oilScientific
Cod liver oil is among the most studied supplements for joint health. EPA and DHA reduce synovial inflammation in RA and other arthropathies. Multiple RCTs demonstrate significant reductions in joint pain, stiffness, and swelling. CLO allows NSAID dose reduction in RA patients.
coixScientific
Coix seed extract significantly reduces joint inflammation, edema, and cartilage-degrading enzyme MMP-3 in animal RA models. A 2025 multi-omics study identified coix seed oil acting via the gut-butyrate-joint axis to suppress NLRP3 inflammasome in joint tissue.
collagenScientific
Hydrolyzed collagen peptides (types I and II) are among the most studied joint supplements. Multiple RCTs show collagen hydrolysate reduces OA joint pain, improves function, and may support cartilage integrity. A 2025 network meta-analysis of 39 RCTs included collagen as an efficacious supplement for knee OA outcomes.
colostrumScientific
Colostrum's anti-inflammatory and immune-modulating components—particularly lactoferrin, PRPs, and immunoglobulins—have mechanistic relevance to joint health. Colostrum has been explored for rheumatoid arthritis due to its ability to regulate the immune response and reduce inflammation. Animal and early clinical data support a role in joint-related inflammatory conditions.
comfreyScientific
Comfrey root extract has robust RCT evidence for joint conditions including osteoarthritis, ankle sprains, and joint pain, with ESCOP listing osteoarthritis, epicondylitis, tendovaginitis, and periarthritis as substantiated indications. Multiple controlled trials demonstrate significant improvements in joint pain, swelling, and mobility. Post-marketing surveillance data confirm real-world effectiveness for joint complaints including morning stiffness reduction of 94%.
commiphoraScientific
Commiphora mukul has clinical outcomes data for osteoarthritis of the knee and extensive animal evidence for anti-arthritic activity. Guggulsterones suppress the NF-κB and COX-2 inflammatory pathways centrally involved in joint inflammation and cartilage degradation.
copperScientific
Copper maintains joint health through lysyl oxidase-mediated cross-linking of collagen in cartilage and tendons. Copper metabolism is altered in rheumatoid arthritis, with elevated serum copper and ceruloplasmin as acute-phase reactants. Copper complexes exhibit anti-inflammatory activity relevant to joint inflammation.
cryptoxanthinScientific
BCX protects joint cartilage from inflammatory degradation by inhibiting aggrecanases and IL-1β-driven cytokines in human chondrocytes. It prevents surgically induced osteoarthritis in animal models and is epidemiologically associated with reduced risk of inflammatory polyarthritis in humans.
curcuminScientific
Curcumin, the primary bioactive of turmeric (Curcuma longa), has extensive clinical evidence for joint health. A meta-analysis of 29 RCTs (2,396 participants, 5 arthritis types) confirmed significant pain and inflammation reductions. A 2014 head-to-head RCT found 1,500 mg/day curcumin equivalent to ibuprofen 1,200 mg/day in knee OA.
currantScientific
Blackcurrant seed oil GLA has been shown in human RCTs to reduce signs and symptoms of joint disease including RA synovitis, morning stiffness, and joint tenderness. GLA metabolites reduce synovial inflammation through prostaglandin E1 and 5-lipoxygenase suppression. Traditional anti-rheumatic use is also well-documented.
d-alpha tocopherolScientific
Alpha-tocopherol has been investigated in rheumatoid arthritis (RA) as an adjunct anti-inflammatory agent, with low-level clinical evidence suggesting benefit in reducing pain and inflammation markers. Active RCTs are underway specifically examining α-tocopherol's effect on RA clinical activity.
devil's clawScientific
Devil's Claw (Harpagophytum procumbens), native to southern Africa, has ESCOP and Commission E monograph support for articular pain. Multiple RCTs show its aqueous/hydroalcoholic extracts (≥50 mg harpagoside/day) significantly reduce pain and improve WOMAC scores in hip and knee OA, comparable to low-dose NSAIDs.
DHA (docosahexaenoic acid)Scientific
DHA is a long-chain omega-3 fatty acid and key component of fish and marine oils with anti-inflammatory joint benefits. It reduces COX/LOX-driven eicosanoid production in synovial tissue. Clinical evidence for DHA in joint conditions is primarily from combined EPA+DHA omega-3 trials in RA and OA.
DHEA (dehydroepiandrosterone)Scientific
DHEA has anti-inflammatory properties relevant to joint health, including inhibition of proinflammatory cytokines via NF-κB blockade and modulation of MMP activity in chondrocytes. Low DHEA levels are observed in rheumatoid arthritis and SLE. Animal studies demonstrate DHEA reduces experimental arthritis severity; DHEA modulates the MMP/PGE2 imbalance in chondrocytes with potential protective effects on articular cartilage.
docosahexaenoic acidScientific
DHA and EPA reduce joint inflammation by modulating eicosanoid synthesis and decreasing pro-inflammatory cytokines (TNF-α, IL-1β). DHA-derived resolvins actively promote resolution of joint inflammation. Clinical RCTs of EPA+DHA in rheumatoid arthritis show modest reductions in joint pain, morning stiffness, and tender joint counts.
dog roseScientific
Dog Rose rosehip preparations have the strongest human clinical evidence for joint health of any herbal remedy in this class, demonstrating improvements in joint pain, stiffness, and mobility in OA patients across multiple RCTs. Effects are driven by inhibition of joint-destructive inflammatory pathways including NF-κB, COX-1/2, and pro-inflammatory cytokines.
dong quaiScientific
A. sinensis and its constituents suppress key mediators of joint destruction in preclinical models of both rheumatoid arthritis and osteoarthritis, including COX-2, PGE2, MMP-1, MMP-3, and RANKL-induced osteoclast differentiation. Ferulic acid modifies immune cells and cytokines involved in joint health. Traditional TCM applies Dong Quai to rheumatic joint complaints.
DPA (docosapentaenoic acid)Scientific
DPA modulates pro-inflammatory cytokine and eicosanoid production relevant to joint inflammation. Preclinical studies suggest DPA suppresses pathways involved in joint inflammation and cartilage degradation, and DPA plasma levels rose following probiotic treatment in rheumatoid arthritis mouse models. Evidence is primarily preclinical with supporting mechanistic data.
EGCG (epigallocatechin gallate)Scientific
EGCG reduces joint inflammation, cartilage catabolism, and bone erosion in rheumatoid and osteoarthritis models. It inhibits NF-κB-driven synovial inflammation, suppresses osteoclastogenesis, and protects chondrocytes from cytokine-mediated destruction, with early oral administration producing effects comparable to methotrexate in animal models.
eggScientific
Eggshell membrane (ESM) supplementation at 300–500 mg/day has been shown in multiple RCTs to reduce joint pain and stiffness in knee osteoarthritis and to improve joint mobility and strength, through provision of structural joint matrix components including collagen, hyaluronic acid, glucosamine, and chondroitin.
eicosapentaenoic acidScientific
EPA is one of the best-supported nutritional interventions for joint inflammation, with 17 of 18 RCTs finding benefit in RA. EPA reduces synovial IL-1β, TNF-α, leukotriene B4, morning stiffness, and tender joint counts. EPA is also a precursor to resolvins that actively resolve joint inflammation.
enicostemma littoraleScientific
Preclinical evidence in the Complete Freund's adjuvant arthritis model demonstrates reduction of joint edema (paw volume decrease of 15.81%) and elevation of joint antioxidant enzymes by E. littorale. Traditional Siddha and Ayurvedic use for rheumatism and joint inflammation is also well-documented.
EPA (eicosapentaenoic acid)Scientific
EPA is the primary omega-3 fatty acid responsible for reducing joint inflammation in RA and OA. It competitively inhibits arachidonic acid-derived COX and LOX eicosanoid pathways. Cochrane meta-analysis of 17 RA RCTs confirms EPA+DHA reduces joint pain, tenderness, and morning stiffness.
eucalyptusScientific
Eucalyptus oil applied topically or inhaled has demonstrated anti-inflammatory and analgesic effects on joints in clinical RCTs, including in post-total knee replacement patients and in rheumatoid arthritis. 1,8-Cineole suppresses synovial inflammatory mediators. Topical eucalyptus is widely used in joint pain products.
evening primrose oilScientific
EPO's GLA content modulates joint inflammation via eicosanoid pathway competition, and multiple RCTs have examined EPO in rheumatoid arthritis with mixed but generally positive results for symptom measures. The 2024 systematic review identified RA as one of the conditions with the most positive EPO evidence.
fenugreekScientific
Fenugreek seeds exhibit significant anti-arthritic activity in preclinical models via NF-κB inhibition, COX/LOX suppression, and reduction of pro-inflammatory cytokines and paw edema. Clinical menopausal RCTs with fenugreek extract report significant reductions in leg and joint pain as secondary outcomes in human subjects.
feverfewScientific
Parthenolide inhibits ICAM-1 on synovial fibroblasts, reduces T-cell adhesion, and suppresses IL-1β and TNF-α in chondrocytes. One clinical RCT (n=40) in rheumatoid arthritis patients found no significant benefit. Traditional use for joint pain is extensively documented across European herbal medicine.
fisetinScientific
Fisetin targets senescent chondrocytes and synoviocytes that drive osteoarthritis pathology, and its anti-inflammatory NF-κB/MAPK pathway suppression addresses arthritic inflammation. Senescent cells in joints are directly linked to OA in murine models.
fish oilScientific
Fish oil provides EPA and DHA, omega-3 fatty acids with robust evidence for reducing joint inflammation in RA and supporting OA. A Cochrane meta-analysis of 17 RCTs confirmed fish oil reduces RA joint pain, tenderness, and morning stiffness, and reduces NSAID use. It also benefits OA via anti-inflammatory mechanisms.
flaxseedScientific
Flaxseed's ALA omega-3 is a structural component of joint cell membranes and a precursor to anti-inflammatory eicosanoids that reduce synovial inflammation. Clinical trials in RA patients show benefits for joint pain, stiffness, and disease activity. Versus Arthritis confirms ALA's role in joint cell structure and function.
flowering quinceScientific
C. speciosa's most prominent traditional and pharmacological application involves joint health, particularly in rheumatic and arthritic conditions. Preclinical studies confirm suppression of synovial inflammation, joint swelling, cartilage protection, and pain reduction via multiple molecular mechanisms.
gardenia jasminoidesScientific
Geniposide from Gardenia jasminoides has demonstrated anti-arthritic effects in adjuvant-induced arthritis and osteoarthritis animal models, acting on synoviocytes and mesenteric lymphoid tissue to suppress joint inflammation. Traditional TCM use includes external application for joint swelling and contusion pain. Evidence is preclinical.
garlic bulbScientific
Garlic's anti-inflammatory organosulfur compounds—inhibiting COX, TNF-α, IL-1β, and IL-6—directly target the inflammatory pathways driving joint destruction in both RA and OA. A double-blind RCT in 70 RA patients confirmed significant improvements in tender joint count, pain, disease activity, and CRP with garlic supplementation.
gastrodiaScientific
GE n-butanol extract reduced paw swelling, improved joint radiology and histology, and suppressed inflammatory cytokines in CFA-induced arthritis rats via MAPK pathway inhibition. This represents the primary evidence for GE's effects on joints.
gentianScientific
Gentiopicroside from Gentiana species has been shown in preclinical studies to protect articular chondrocytes from IL-1β-induced degradation, inhibiting MAPK signaling pathways and reducing MMP expression. A 2025 CIA rat model study confirmed anti-RA joint effects including osteoclastogenesis inhibition. Traditional Chinese medicine Gentiana (Qin Jiao) is a classical herb for joint pain and bi-syndrome.
gentian rootScientific
Gentiana macrophylla (Qin Jiao) is the gentian species with the most established joint-related evidence, used in TCM for joint pain, stiffness, and arthritis. Multiple preclinical studies demonstrate significant anti-inflammatory effects in rodent RA and osteoarthritis models via PGE2 suppression and NF-κB/NLRP3 pathway inhibition. G. lutea leaf extract also showed anti-arthritic activity in a 2026 rat model. No human RCTs on joints exist.
gentiana macrophyllaScientific
Joints are the primary target of Gentiana macrophylla's pharmacological activity. Preclinical studies demonstrate significant reduction of joint inflammation in both RA and general arthritis models. Iridoid glycosides from G. macrophylla flowers tested in collagen-induced arthritis showed reduced inflammatory cytokines. Its TCM indication for 'Bi syndrome' (joint obstruction) spans over 2,000 years.
gingerScientific
Ginger (Zingiber officinale) root extracts have been evaluated in multiple RCTs for knee OA, showing modest pain reduction and improved mobility. A landmark RCT (Altman & Marcussen, Arthritis Rheum 2001) found ginger extract superior to placebo for knee OA pain. Its mechanisms involve COX and LOX inhibition via gingerols and shogaols.
ginsengScientific
Clinical evidence from a 12-week RCT in postmenopausal women demonstrates that 3 g/day ginseng extract significantly improved WOMAC joint symptom scores, and ginsenosides have documented anti-inflammatory properties relevant to synovial and cartilage tissue. Ginsenosides inhibit pro-inflammatory cytokines and NF-κB signaling, which are central mediators of joint inflammation. The dedicated clinical trial base for joint outcomes specifically is small but positive.
GLA (gamma linolenic acid)Scientific
GLA has the most robust clinical evidence of any dietary supplement for joint inflammation in rheumatoid arthritis. Multiple RCTs with doses of 1.4–2.8 g/day show significant reductions in joint tenderness, swelling, and disease activity scores. GLA suppresses synovial inflammation through DGLA-mediated inhibition of prostaglandins, leukotrienes, and cytokines.
glucosamineScientific
Glucosamine is an amino sugar naturally present in articular cartilage and synovial fluid. Multiple RCTs and systematic reviews support its use for osteoarthritis (OA), particularly glucosamine sulfate, showing reductions in joint pain and slowing of cartilage degradation. A 2019 systematic review and meta-analysis confirmed pain reduction and joint-space preservation effects. Typical doses are 1,500 mg/day.
glycineScientific
Glycine is the dominant amino acid in articular collagen, directly limiting cartilage collagen synthesis. Multiple RCTs of glycine-rich collagen peptides show reduction in joint pain, improved physical function, and cartilage support in osteoarthritis. In vitro data confirm higher glycine concentrations directly increase collagen synthesis by articular chondrocytes.
glycosaminoglycansScientific
Glycosaminoglycans (GAGs) including chondroitin sulfate, heparan sulfate, and hyaluronic acid are structural components of articular cartilage and synovial fluid with established roles in joint health. Supplemental GAGs (primarily chondroitin and HA) have significant RCT evidence for OA pain reduction and cartilage support.
goldenrodScientific
Goldenrod-containing preparations (Phytodolor) have been evaluated in clinical studies for rheumatic joint conditions including osteoarthritis and rheumatoid arthritis, showing efficacy comparable to average-dose NSAIDs in a review of 11 human studies. Anti-inflammatory and analgesic actions of goldenrod constituents are pharmacologically characterized. The German Commission E endorses goldenrod preparations for rheumatic complaints.
grape seedScientific
GSPE demonstrated chondroprotective and antinociceptive effects in rat osteoarthritis models and significantly reduced arthritic inflammation in rheumatoid arthritis models via T-cell and cytokine rebalancing. ScienceDirect reviews cite clinical trial evidence for GSE's anti-inflammatory effects on arthropathies. Direct large-scale human joint RCTs are not yet available.
gravel rootScientific
Gravel root has pre-clinical in vitro and animal evidence supporting anti-inflammatory activity relevant to joint inflammation, specifically through cistifolin's inhibition of integrin-mediated leukocyte adhesion and reduction of carrageenan-induced edema in rats.
green chirettaScientific
Green chiretta has direct clinical evidence for joint health via RCTs in rheumatoid arthritis and osteoarthritis. Andrographolide inhibits synovial NF-κB, reduces cartilage-degrading metalloproteinases, and suppresses IL-1β–driven joint inflammation in both preclinical and clinical contexts.
green-lipped musselScientific
Green-lipped mussel (Perna canaliculus) from New Zealand contains unique omega-3 fatty acids, glycosaminoglycans, and other bioactives with anti-inflammatory and joint-protective properties. A 2021 systematic review found small-to-moderate improvements in OA pain and joint function. A 2021 rat OA model study confirmed reduction in IL-1β and IL-6 in joint tissue.
guggulScientific
Joints represent the best-documented body system target for guggul beyond lipids. Clinical case studies, Ayurvedic RCTs, and extensive preclinical data support benefit in osteoarthritis and rheumatoid arthritis. Guggulsterones suppress joint-destructive inflammatory pathways at multiple molecular levels.
harpagosideScientific
Harpagoside is the primary iridoid glycoside marker compound in Devil's Claw (Harpagophytum procumbens), standardized in clinical extracts used for joint pain. RCTs using extracts providing ≥50 mg harpagoside/day demonstrate consistent pain relief in hip and knee OA. ESCOP monograph endorses harpagoside-standardized extracts for articular pain.
hesperetinScientific
Hesperetin protects joint chondrocytes from inflammatory damage via AMPK-NF-κB pathway inhibition, demonstrated in both human chondrocyte in vitro studies and animal osteoarthritis models. This provides mechanistic scientific evidence for joint health relevance.
hesperidinScientific
Hesperidin's anti-inflammatory mechanisms (NF-κB inhibition, COX-2 suppression, cytokine reduction) are directly relevant to joint inflammation and arthritis. Preclinical studies in arthritis models show hesperidin reduces joint inflammatory markers and oxidative stress. Clinical evidence specific to joints is limited to indirect anti-inflammatory RCT data.
hyaluronic acidScientific
Hyaluronic acid (HA) is a native component of synovial fluid that provides lubrication and viscoelastic support to joints. Intra-articular injections have strong evidence for knee OA. Oral HA supplementation has growing RCT evidence for joint pain reduction, particularly in knee OA.
impatiensScientific
Joint pain and articular rheumatism represent core traditional indications for Impatiens across Chinese, Indian, Korean, and Ethiopian medicine. Animal model studies confirm antiarthritic activity of I. balsamina in rheumatoid arthritis models, and COX-2 inhibitory activity provides mechanistic support.
indian frankincenseScientific
Joints are the primary clinical target of Boswellia serrata, with the strongest and most consistent human RCT evidence. A meta-analysis of 7 OA RCTs (n=545) confirmed significant improvements in joint pain, stiffness, and function. Clinical effects include reduced swelling, increased flexion, improved walking distance, and radiographic evidence of joint space preservation.
indian gum arabic treeScientific
A clinical study of 40 rheumatoid arthritis patients on gum arabic (30 g/day, 12 weeks) showed reductions in swollen and tender joint counts, TNF-α, and ESR. Animal studies confirm potent anti-inflammatory and analgesic effects of A. nilotica extracts in joint pain models.
knotweedScientific
PC extract reduces joint inflammation markers (TNF-alpha, IL-6, CRP) in animal arthritis models and demonstrates analgesic effects. Topical PC extract reduces inflammatory skin/tissue responses. TCM uses Hu Zhang for joint pain, blood stasis in joints, and osteomyelitis. Resveratrol inhibits COX-2 and NF-κB relevant to synovial inflammation.
krill oilScientific
Krill oil provides omega-3 fatty acids (EPA/DHA) in phospholipid form with superior bioavailability versus fish oil, plus astaxanthin. A 6-month multicenter, double-blind, placebo-controlled RCT demonstrated krill oil significantly improved mild-to-moderate knee OA pain. A 2025 network meta-analysis ranked krill oil among effective supplements for KOA function.
kudzuScientific
Kudzu root has traditional use for joint swelling and arthritis and clinical evidence from a human RCT demonstrating reduction in the cartilage degradation biomarker CTX-II in menopausal women. Anti-inflammatory mechanisms (NF-κB suppression) and phytoestrogenic effects provide a mechanistic basis for joint protection, especially in post-menopausal osteoarthritis.
L-glycineScientific
Joints depend on type II collagen (cartilage), type I collagen (ligaments, tendons), and synovial fluid proteoglycans—all requiring glycine as a structural building block. Glycine's anti-inflammatory properties also suppress synovial inflammation. Clinical RCTs with glycine-rich collagen peptides demonstrate improvements in joint pain scores and physical function in osteoarthritis patients.
L-methionineScientific
SAMe, derived from L-methionine, has been studied in 14 clinical trials for osteoarthritis, demonstrating analgesic and chondroprotective effects comparable to NSAIDs. SAMe stimulates proteoglycan synthesis in chondrocytes and exhibits anti-inflammatory properties. A Cochrane review found potentially clinically relevant effects on pain and function, though evidence quality was low-to-moderate.
L-prolineScientific
Joint cartilage, synovium, tendons, and ligaments are all collagen-dense tissues requiring proline as a primary structural amino acid. RCTs of proline-rich collagen peptides in knee osteoarthritis have demonstrated improvements in pain, stiffness, and functional capacity. Hydroxyproline-proline dipeptides absorbed after collagen peptide ingestion act as chemotactic triggers for cartilage fibroblasts.
lactobacillus caseiScientific
L. casei 01 has clinical evidence for reducing joint inflammation in RA patients. A double-blind RCT showed significant reductions in DAS28, tender/swollen joint counts, and serum hs-CRP after 8 weeks of L. casei 01 supplementation. Animal models using collagen-induced arthritis show L. casei reduces synovial inflammation, pannus formation, and cartilage destruction.
lemonScientific
Lemon's vitamin C supports joint health through collagen synthesis for cartilage and synovial tissues, and its flavonoids reduce joint-relevant inflammatory cytokines. Vitamin C deficiency causes joint aches, hemarthrosis, and impaired connective tissue integrity—all reversed by vitamin C repletion.
luteolinScientific
Luteolin reduces joint inflammation, synoviocyte proliferation, cartilage degradation, and pain in preclinical models of rheumatoid and osteoarthritis through NF-κB, COX-2, and MAPK pathway suppression.
manganeseScientific
Manganese is an essential trace mineral required as a cofactor for glycosaminoglycan synthesis enzymes in cartilage, including manganese superoxide dismutase (MnSOD). Deficiency impairs proteoglycan formation in joint cartilage. It is frequently included in joint support formulations alongside glucosamine and chondroitin.
mangosteenScientific
Mangosteen xanthones inhibit COX-1, COX-2, NF-κB, TNF-α, and IL-1β—the key mediators of joint inflammation in both osteoarthritis and rheumatoid arthritis. Animal paw-swelling models show significant anti-inflammatory effects. Human RCTs demonstrate reductions in systemic CRP and cytokines relevant to joint inflammation, though no joint-specific RCTs have been conducted.
menthol oilScientific
Topical menthol is used for joint pain relief in osteoarthritis and arthritis, with clinical studies demonstrating reduced pain and improved function. The FDA approves it as an OTC counterirritant for minor joint pain.
morindaScientific
Morinda iridoid glycosides and anthraquinones target joint inflammation through NF-κB, MAPK, JAK2/STAT3, and GSK-3β pathway inhibition in synovial fibroblasts and macrophages. Animal models of collagen-induced and adjuvant-induced arthritis show reduced paw swelling, arthritic score, and inflammatory cytokines. Traditional TCM use for joint pain is millennia-old.
MSM (methylsulfonylmethane)Scientific
MSM is an organosulfur compound used widely for joint pain in OA. Multiple RCTs show modest reductions in joint pain and stiffness, particularly in knee OA, at doses of 1.5–3 g twice daily. A systematic review confirmed these benefits. It is a component of sulfur-containing amino acids important for collagen and cartilage synthesis.
mugwortScientific
A. vulgaris extracts inhibit xanthine oxidase and suppress inflammatory cytokines in vitro, with relevance to gout and inflammatory joint disease. Moxibustion is clinically applied for osteoarthritis. Preclinical anti-inflammatory rodent studies show significant joint edema inhibition. Medieval European medicine used A. vulgaris externally against gout.
mustardScientific
Mustard plasters have direct documented clinical evidence for reducing knee pain in osteoarthritis (PMC11426707) and are traditionally used for all arthritic joint conditions. AITC's counterirritant rubefacient mechanism increases joint-area blood flow, and systemic anti-inflammatory isothiocyanate action supports joint tissue health.
myristoleateScientific
Joints are the primary therapeutic target of cetyl myristoleate research. Multiple human RCTs have evaluated CMO for osteoarthritis, rheumatoid arthritis, and related joint conditions, measuring pain, swelling, and range of motion outcomes. CMO acts as both a joint lubricant and an anti-inflammatory agent reducing prostaglandin and leukotriene production in synovial tissue.
myrobalanScientific
A randomized, double-blind, placebo-controlled trial (n=105, 84 days) of standardized TC extract showed significant improvements in joint mobility, comfort, and functional capacity. Preclinical antiarthritic activity and traditional use for arthritis and gout across multiple Asian medicine systems are also documented.
myrrhScientific
Myrrh and myrrh-containing TCM formulations have documented anti-inflammatory and analgesic effects relevant to joint health. Guggulsterone acts on joint inflammatory pathways. TCM myrrh-based formulations for arthritis have clinical documentation. Animal studies confirm anti-inflammatory efficacy relevant to joint inflammation.
N-acetyl-glucosamineScientific
NAG is a direct substrate for hyaluronic acid and chondroitin sulfate biosynthesis within joints—the key GAGs in synovial fluid and articular cartilage. Clinical and preclinical data show favorable cartilage metabolism, reduced synovial inflammation, and improved joint function with NAG supplementation.
nettleScientific
Stinging nettle (Urtica dioica) leaf has been used traditionally in European herbal medicine for arthritis and joint pain, with modern evidence supporting anti-inflammatory mechanisms. An RCT showed that stewed nettle leaf reduced NSAID use in OA patients. Active lectins and polysaccharides modulate NF-κB and TNF-α.
nut grassScientific
C. rotundus demonstrates anti-arthritic activity in formaldehyde-induced arthritis models and anti-inflammatory effects relevant to joint inflammation. It is listed in the PMC 2018 review as having anti-arthritic as a proven activity. Traditional use for joint pain and swelling is documented.
oleanolic acidScientific
OA reduces synovial inflammation in osteoarthritis by suppressing IL-1β-induced fibroblast-like synoviocyte dysfunction via the SIRT3-NF-κB axis, inhibiting cartilage-degrading enzymes (MMP3, ADAMTS4), COX-2, PGE2, and reducing intra-articular oxidative stress.
oliveScientific
Olive polyphenols target joint inflammation through COX-1/COX-2 inhibition (oleocanthal), NF-κB suppression, and direct reduction of TNF-α and IL-1β in RA patient PBMCs. Early clinical studies suggest pain and mobility benefit in osteoarthritis. Human cell evidence from RA patients (2025) provides direct joint-relevant immunological data.
olive oilScientific
EVOO polyphenols suppress joint inflammatory mediators including COX-2, MMP-1, MMP-3, IL-6, and TNF-α in synovial tissue. Oleocanthal's COX inhibitory activity is mechanistically analogous to ibuprofen. Epidemiological data link Mediterranean diet with EVOO to lower arthritis prevalence and reduced joint inflammation markers.
omega-3 fatty acidsScientific
Omega-3 fatty acids (EPA and DHA) from fish and marine sources have robust evidence for reducing joint inflammation in rheumatoid arthritis and moderate evidence for OA. Multiple RCTs show reductions in morning stiffness, tender and swollen joint counts, and NSAID requirements in RA. Animal and clinical data also support OA joint benefits.
omega-6 fatty acidsScientific
GLA-rich omega-6 supplements (evening primrose oil, borage oil) have RCT evidence in inflammatory joint disease, particularly rheumatoid arthritis. A 6-month double-blind trial of 56 RA patients using 2.8 g/day GLA showed meaningful joint symptom improvements. A 60-patient RCT found that combined fish oil and EPO significantly reduced DAS28 scores, tender joints, and VAS pain. Evidence is more robust for GLA than for LA or AA in joint-specific outcomes.
omega-9 fatty acidsScientific
Oleic acid (omega-9) reduces joint-relevant pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) through NF-κB and PPAR-γ pathways. Mediterranean dietary patterns rich in OA are associated with lower inflammatory burden relevant to joint disease. Some human dietary trial data support anti-inflammatory benefits in inflammatory conditions affecting joints.
onionScientific
Onion's primary flavonoid quercetin has demonstrated anti-arthritic activity in both experimental models and human clinical contexts by targeting inflammatory markers including COX-2 and NF-κB signaling. Traditional use for rheumatic conditions and 'swelling after bee stings' is also documented. Quercetin targets the same inflammatory pathways underlying synovial joint inflammation.
paederia foetidaScientific
P. foetida has documented antiarthritic and anti-inflammatory effects relevant to joints, supported by preclinical studies since the 1960s and by extensive traditional use across multiple Asian medical systems for rheumatism, arthritis, gout, and joint stiffness.
partheniumScientific
Feverfew has documented mechanistic and limited clinical evidence for joint health, rooted in its anti-inflammatory effects on synovial fibroblasts, NF-κB inhibition, and enzyme release suppression in inflamed joints. The RA RCT demonstrated improved grip strength. Joint inflammation remains a core traditional and pharmacologically-supported indication.
PEA (palmitoylethanolamide)Scientific
Palmitoylethanolamide (PEA) is an endogenous N-acylethanolamine with analgesic and anti-inflammatory effects relevant to joint pain. Clinical studies support its use for OA joint pain, particularly in combination with OA therapies. ConsumerLab lists PEA among joint health supplements with emerging evidence.
peonyScientific
TGP has the most robust clinical evidence base among peony's applications, with multiple meta-analyses confirming efficacy as adjunctive therapy for RA and other inflammatory joint diseases, reducing swollen joint count, ESR, and disease activity scores.
peptidaseScientific
Proteolytic enzyme combinations have been directly tested for joint-related outcomes in osteoarthritis clinical trials. A randomized trial versus diclofenac found oral enzyme combinations comparable to NSAIDs for knee OA pain and function. A 2022 review of nine OA clinical studies and a 10-study review of bromelain both support efficacy for joint pain and stiffness.
phellodendronScientific
Phellodendron amurense (cork tree) bark has been evaluated in combination with Citrus sinensis for knee OA in a pilot double-blind RCT (n=80, 8 weeks), showing significant reductions in Lequesne Algofunctional Index scores and CRP. Berberine and phellodendrine, key alkaloids, inhibit NF-κB and COX-2.
phellodendron amurenseScientific
Phellodendron amurense (Amur corktree) bark is used in TCM for inflammatory joint conditions (damp-heat Bi syndrome). A pilot double-blind RCT in knee OA found significant LAI and CRP reductions. Berberine, its primary alkaloid, inhibits NF-κB, COX-2, and inflammatory cytokines in synoviocytes.
pineScientific
Three identically designed, randomized, double-blind, placebo-controlled trials in patients with mild osteoarthritis (stages I–II) using 150 mg/day Pycnogenol for 3 months showed reductions in pain, stiffness, and WOMAC scores. A 2017 pilot RCT in 33 severe OA patients showed significant downregulation of cartilage-degrading enzymes MMP-3, MMP-13, and IL-1β in chondrocytes.
pine barkScientific
Pine bark extract (especially maritime pine, Pinus pinaster—sold as Pycnogenol) contains oligomeric proanthocyanidins with anti-inflammatory and antioxidant activity. Multiple RCTs in knee OA demonstrate significant WOMAC pain and stiffness reductions. European traditional use for inflammatory conditions is also documented.
pineappleScientific
Multiple clinical trials support bromelain's benefit to joint health in osteoarthritis and rheumatoid arthritis, reducing pain, stiffness, and inflammatory markers. One RCT found bromelain comparable to the NSAID diclofenac in hip OA. Manganese in pineapple supports cartilage matrix synthesis.
pistacia integerrima gallScientific
P. integerrima gall extracts demonstrate in vivo analgesic and anti-inflammatory activity in joint-relevant models (carrageenan paw edema, formalin paw licking). Separately, xanthine oxidase inhibitory activity and serum uric acid lowering in hyperuricemic mice support relevance to gouty joint disease. Traditional use as antirheumatic is documented.
pomegranateScientific
Five clinical studies (one pilot, four RCTs) support pomegranate as a complementary therapy for joint inflammation in RA and OA, reducing disease activity scores, CRP, and oxidative stress. Pomegranate inhibits NF-κB and synovial cell inflammation in vitro and reduces articular inflammatory cell infiltration in animal models.
pregnenoloneScientific
Pregnenolone's analgesic and anti-inflammatory properties are clinically demonstrated in musculoskeletal pain contexts. A veterans' RCT (JAMA Network Open 2020) showed reduced joint-area and activity-related pain interference. Pregnenolone's TLR pathway suppression reduces inflammatory signaling relevant to joint inflammation.
prickly ashScientific
Joints are a primary target for prickly ash with both preclinical evidence and traditional documentation. Animal studies show reduction in joint inflammation, paw swelling, and pro-inflammatory cytokines. The 2025 PMC rat RA model study mechanistically validates alkaloid effects on synovial cell proliferation. Traditional anti-rheumatic use is extensively documented across Native American, Eclectic, and TCM traditions.
prickly pear cactusScientific
In human chondrocyte cell cultures, lyophilized O. ficus-indica cladode extract significantly reduced IL-1β-induced production of NO, glycosaminoglycans, PGE-2, and ROS — key mediators of joint cartilage degradation. In vivo anti-arthritic activity was confirmed in rodent CFA models. Traditional use for rheumatic pain is documented.
proteoglycansScientific
Proteoglycans are critical macromolecules of articular cartilage matrix, depleted in OA. Supplemental proteoglycan fractions from bovine or marine sources are used to support joint cartilage integrity. The chondroitin and glucosamine precursors of proteoglycans represent the best-evidenced joint supplements.
punarnavaScientific
B. diffusa root extract demonstrated anti-arthritic activity in adjuvant-induced arthritis rats. Traditional use of leaf poultices for joint swelling is documented in tribal medicine, and Ayurvedic formulations Narayan Oil and Punarnavadi Guggulu are specifically for joint and musculoskeletal conditions. Anti-inflammatory mechanisms (NF-κB, cytokine inhibition) are well-characterized.
purslaneScientific
A 2024 double-blind RCT was conducted specifically in rheumatoid arthritis patients measuring inflammatory and antioxidant joint-related markers. Traditional use of purslane for arthritis, gout, and joint pain is extensively documented. Omega-3 ALA and flavonoids provide anti-inflammatory mechanisms relevant to joint health.
pycnogenolScientific
Pycnogenol (French maritime pine bark extract, Pinus pinaster) is standardized to oligomeric proanthocyanidins (OPCs). Multiple RCTs in OA patients show significant reductions in pain, stiffness, and WOMAC scores. It inhibits NF-κB, COX-2, and MMPs, and reduces CRP and inflammatory cytokines.
queen of the meadowScientific
Joint health is the body system with the strongest combined traditional and pre-clinical scientific evidence for queen of the meadow. The EMA formally recognizes it for minor joint pain. COX inhibition, prostaglandin reduction in human platelets ex vivo, and in vivo carrageenan-induced edema reduction have been demonstrated in peer-reviewed studies.
quercetinScientific
Quercetin is a flavonol found widely in plants with potent anti-inflammatory and antioxidant properties. In vitro and animal studies show it inhibits IL-1β, TNF-α, and MMP activity in chondrocytes. Small clinical trials support modest joint pain reduction in OA. It is often combined with other joint supplements.
rehmanniaScientific
Rehmannia demonstrates anti-inflammatory and analgesic effects on joints in both RA and OA experimental models. Catalpol suppresses Th17/STAT3 signalling in RA, while Rehmannia alcohol extract reduces multiple inflammatory markers and delays cartilage degradation in OA via TLR4/NF-κB inhibition. The herb has a centuries-long TCM use for joint pain attributed to kidney yin deficiency.
resveratrolScientific
Resveratrol is a stilbenoid polyphenol found in grapes and red wine with anti-inflammatory and anti-catabolic effects in cartilage. In vitro studies show inhibition of IL-1β-induced MMP and prostaglandin production in chondrocytes. Small RCTs in OA patients show modest improvements in joint pain and biomarker reductions.
roseScientific
Rosehip powder has the strongest herbal evidence for joint health, with a meta-analysis of three RCTs (n=287) showing patients twice as likely to respond versus placebo for arthritic pain. Polyphenols and anthocyanins in rosehip ease joint inflammation and protect against joint damage. RCTs cover both osteoarthritis and rheumatoid arthritis.
rose hipsScientific
Rosehip powder (Rosa canina) has been evaluated in RCTs for OA and shows significant pain relief. A meta-analysis of 3 RCTs (n=306) found a statistically significant pain reduction (ES 0.37, p=0.0019) and reduced rescue medication use versus placebo. Active constituents include galactolipids (GOPO), vitamin C, and carotenoids.
rosemaryScientific
Oral rosemary leaf powder significantly reduced disease activity scores, joint counts, and inflammatory markers in a 12-week double-blind RCT in rheumatoid arthritis patients. Topical rosemary oil has also reduced joint pain in massage-based clinical trials. Anti-inflammatory bioactives in rosemary target NF-κB, COX-2, and cytokines central to joint inflammation.
rosmarinic acidScientific
Rosmarinic acid exerts documented anti-arthritic effects on joint tissues via NF-κB inhibition in synoviocytes, MMP suppression protecting cartilage collagen, reduction of synovial pro-inflammatory cytokines, and direct apoptosis of activated T cells from rheumatoid arthritis patients. These mechanisms are supported by human-cell-level evidence and multiple animal arthritis models.
rubia cordifoliaScientific
R. cordifolia has been investigated in adjuvant-induced arthritis animal models, demonstrating reduction of TNF-α, IL-1β, and PGE2 via COX-2 inhibition and phospholipase pathway modulation. Traditional Korean, Chinese, and Indian medicine systems document its use for arthritis and rheumatism. Alizarin and mollugin are the principal COX-2-inhibiting constituents.
rutinScientific
Rutoside inhibited TNF-α, IL-1, IL-6, and nitric oxide from human activated macrophages in vitro (Bordeaux University, 2008) and reduced arthritic signs in adjuvant-induced arthritis animal models. Multiple preclinical arthritis models show rutin reduces joint inflammation, cartilage degradation, and pain behaviors.
safflowerScientific
Safflower has traditional use across TCM, Ayurveda, and Persian/Iranian medicine for joint conditions including rheumatism, rheumatoid arthritis, and sciatica. Animal models show safflower extract reduces paw edema by up to 45% at 200 mg/kg, comparable to low-dose NSAIDs. Its active compounds, particularly hydroxysafflor yellow A and safflomin C, alleviate inflammatory joint conditions. Safflower-infused oils are traditionally massaged into joints for arthritis and muscle aches.
salicinScientific
Multiple RCTs have evaluated salicin-containing willow bark extract for joint pain in osteoarthritis and arthritis broadly. A 2023 meta-analysis of six RCTs (n=329 arthritis patients) found significant pain relief and improved physical function versus placebo, confirming joints as a scientifically studied target.
SAMe (S-adenosyl-L-methionine)Scientific
SAMe (S-adenosylmethionine) is a naturally produced methyl donor studied for OA. Clinical trials show efficacy comparable to NSAIDs for joint pain and stiffness, particularly in knee OA. The Arthritis Foundation notes some studies found it as effective as NSAIDs for improving joint pain and function, though results are inconsistent.
sarsaparillaScientific
Joint-related uses—arthritis, gout, rheumatism—have the most consistent preclinical scientific support of any body system for sarsaparilla. Multiple animal models confirm anti-inflammatory effects in joint tissue; urate-lowering activity in gout models has been demonstrated. A case report in a peer-reviewed journal documents clinical joint benefit. Human RCT evidence is absent.
schizonepetaScientific
Preclinical studies document Schizonepeta's anti-inflammatory and anti-osteoclast properties relevant to joint disease, including the BMC 2016 study on bone erosion in a model relevant to inflammatory arthritis. TCM also uses it for wind-damp joint conditions. No human joint-specific trials exist.
serratiopeptidaseScientific
Joints are among the primary clinical targets of serratiopeptidase, with documented use for osteoarthritis, rheumatoid arthritis, osteoarticular infection, and carpal tunnel syndrome. Multiple clinical reviews confirm SRP's anti-inflammatory and analgesic use in joint conditions. A 1999 preliminary trial (Panagariya and Sharma, JAPI) found improvement in 65% of carpal tunnel syndrome patients.
sesameScientific
Sesame's effects on joints are documented through a clinical trial in knee osteoarthritis (50 patients, 40 g/day sesame for 2 months) showing significant within-group reductions in MDA and hs-CRP. Sesamol and sesame oil inhibit joint-damaging cytokines (TNF-α, IL-1β, IL-6), COX-2, MMPs, and modulate MAPK, PI3K/Akt, and Nrf2 pathways that control cartilage degradation and bone resorption.
shark cartilageScientific
Shark cartilage is a source of chondroitin sulfate, type II collagen, and other glycosaminoglycans used traditionally and scientifically for joint health. While clinical RCT evidence for crude shark cartilage in OA is limited, the chondroitin and collagen fractions it provides are well-supported by broader evidence.
shea butterScientific
Shea nut oil triterpene concentrate (SheaFlex75) attenuated knee osteoarthritis progression in a rat surgical model. Traditional use for joint pain and arthritis is extensively documented in Sub-Saharan Africa. The anti-inflammatory triterpenes in shea butter target the inflammatory mediators underlying joint destruction.
sichuan pepperScientific
Z. bungeanum polyphenols suppress synovial inflammation via NF-κB/MAPK pathways in arthritis animal models. Seed oil inhibits osteoclastogenesis via ERK/c-JUN/NFATc1, relevant to joint bone erosion. TCM uses it for cold-damp bi syndrome (joint pain). Evidence is preclinical.
siler rootScientific
SD has direct preclinical evidence for joint protection in both osteoarthritis and rheumatoid arthritis animal models. Studies demonstrate reduced joint swelling, improved histopathology, lower serum inflammatory cytokines, and cartilage protection. The Chinese Pharmacopoeia officially lists arthralgia among SD's indications, and over 130 TCM formulations use it for joint disease.
siliconScientific
Silicon is required for normal articular cartilage formation, with animal deficiency studies producing malformed joints and collagen-poor cartilage. Silicon is a cofactor for prolyl hydroxylase, essential for collagen synthesis in joint cartilage and synovial tissue. Human evidence for joint-specific outcomes from silicon supplementation is limited and indirect.
smilaxScientific
Smilax extracts and astilbin have been studied in multiple rodent models of joint inflammation, including CFA-induced arthritis, collagen-induced arthritis, and gout. A clinical combination study for ankylosing spondylitis showed markedly improved outcomes with an SGR-containing decoction. Traditional use for joint pain and rheumatism spans multiple continents.
sophoraScientific
S. japonica is noted for anti-osteoporotic and anti-arthritic biological activities in pharmacological reviews. Rutin from S. japonica suppresses oxidative stress in arthritis and S. flavescens alkaloids demonstrate anti-inflammatory effects relevant to joint conditions. These properties are documented in PubMed-indexed research.
soursopScientific
Anti-arthritic and analgesic activity of A. muricata extracts is supported by rodent joint inflammation models and consistent traditional use for rheumatism and arthritic pain across Africa and South America.
spearmint leafScientific
A 16-week human RCT in knee osteoarthritis patients found spearmint tea (both high-rosmarinic and commercial) significantly improved WOMAC stiffness and physical disability scores. High-rosmarinic acid spearmint tea additionally reduced pain scores. Rosmarinic acid's anti-inflammatory and chondroprotective mechanisms are well-characterized.
sphaeranthus indicusScientific
Anti-arthritic activity is among the pharmacologically confirmed properties of S. indicus, with carrageenan paw edema studies demonstrating significant inhibition of joint inflammation. Traditional use covers inflammatory musculoskeletal conditions.
SPMs (specialized pro-resolving mediators)Scientific
SPM levels are reduced in human synovial fluid in both osteoarthritis and rheumatoid arthritis. SPMs reduce joint inflammation, cartilage degradation, and synoviocyte invasiveness. SPMs provide dual pain relief and joint protection without immunosuppression in preclinical arthritis models.
stigmasterolScientific
Stigmasterol has documented anti-arthritic and chondroprotective effects in joint tissue, reducing inflammatory mediators and matrix-degrading enzymes in human OA chondrocytes and in animal OA models including rabbit ACLT and rat MIA models.
strawberryScientific
Two crossover RCTs in obese adults with knee osteoarthritis found 50 g/day of freeze-dried strawberry powder significantly reduced joint pain scores and inflammatory biomarkers including IL-6, IL-1β, MMP-3, and TNF-family cytokines. Strawberry-derived vitamin C also supports joint collagen integrity. Cartilage degradation marker MMP-3 was significantly reduced in strawberry versus control phases.
sulforaphaneScientific
Sulforaphane suppresses Th1/Th17-driven joint inflammation, reduces synoviocyte NF-κB activation, and inhibits MMP expression relevant to cartilage degradation. Preclinical data in arthritis models are supportive. Related autoimmune disease data (psoriasis, SLE) in animal models confirm joint-relevant immunomodulation.
sunflowerScientific
Sunflower head extract demonstrated significant suppression of MSU crystal-induced joint inflammation in a gout animal model, reducing ankle swelling and increasing joint space. Sunflower's anti-inflammatory phenolics and omega-6 fatty acids have relevance to joint inflammation more broadly. Traditional use includes root decoctions for rheumatic joint pain.
sweet wormwoodScientific
Clinical trials in osteoarthritis and rheumatoid arthritis, plus extensive preclinical data, establish A. annua as having significant activity at the joint level. Artemisinins reduce synovial inflammation, fibroblast-like synoviocyte proliferation, and joint damage markers.
szechuan lovageScientific
CX is used clinically in TCM for rheumatic joint pain and osteoarthritis. A 2022 network pharmacology and molecular docking study mapped CX's action on osteoarthritis via MAPK signaling pathways. Ferulic acid from CX has evidence against rheumatoid arthritis. CX's warm, dispersing nature in TCM specifically addresses cold-aggravated joint stiffness.
teaselScientific
Multiple preclinical studies using rat and rabbit arthritis models confirm Dipsacus asper extracts protect articular cartilage, inhibit chondrocyte apoptosis, reduce joint swelling, and modulate inflammatory gene expression. TCM explicitly targets joint pain, stiffness, and weakness as primary indications for teasel root.
terminaliaScientific
T. chebula has multiple RCTs supporting its use for joint health. Double-blind, placebo-controlled trials of standardized T. chebula extract (AyuFlex) found significant reductions in joint pain and discomfort, improved pain threshold and tolerance, and reduced WOMAC scores and knee swelling in clinical populations. Traditional use for arthritis and gout is also well-documented.
tetrahydro iso-alpha acidsScientific
THIAA reduced joint swelling, arthritis index, and joint degradation in a collagen-induced murine arthritis model. A 12-week open-label human case series tested 150 mg nTHIAA with undenatured type II collagen for chronic joint pain in OA and RA patients. THIAA inhibits kinases (BTK, Syk, PI3K) and suppresses NF-κB and PGE2 in pathways driving joint inflammation.
tinospora cordifoliaScientific
T. cordifolia suppresses joint inflammation, bone/cartilage damage, and paw edema in arthritis models via cytokine (IL-1β, TNF-α, IL-6, IL-17) and JAK/STAT pathway inhibition, and protects joint cartilage through Beta-ecdysone-mediated osteogenic activity.
tocotrienolsScientific
Animal models of osteoarthritis demonstrate tocotrienol-mediated joint protection through anti-inflammatory, antioxidant, and chondrocyte self-repair mechanisms. A 2024 Frontiers in Endocrinology review confirmed efficacy in animal OA models. Human clinical trials in this specific application remain scarce.
trans-pterostilbeneScientific
Multiple preclinical studies show pterostilbene reduces cartilage degeneration in OA rat models via Nrf2 activation, NF-κB/PI3K-AKT inhibition, and p53/AMPK/mTOR-driven autophagy, protecting chondrocytes from IL-1β-induced inflammation and extracellular matrix degradation.
triphalaScientific
Triphala protects cartilage by inhibiting hyaluronidase and collagenase, and suppresses joint inflammation through NF-κB and COX-2 inhibition. Animal arthritis studies show Triphala outperforming indomethacin on inflammatory biomarkers. A pilot human study of Triphala Guggulu in osteoarthritis showed clinical improvement.
trypsinScientific
Oral trypsin-containing enzyme preparations have the strongest evidence base in joint disease, specifically knee osteoarthritis, where multiple RCTs demonstrate equivalence to NSAIDs for pain and function. A 2025 crossover RCT showed additional reductions in cartilage degradation and systemic inflammatory markers. Evidence extends to sprained joints and post-orthopedic-surgical joint swelling.
turmericScientific
Turmeric (Curcuma longa) root contains curcuminoids, primarily curcumin, with strong RCT evidence for joint pain and inflammation in OA and RA. A 2022 meta-analysis of 29 RCTs confirmed its efficacy across multiple arthritis types. Historically used in Ayurvedic medicine for joint and musculoskeletal conditions.
urolithin aScientific
Preclinical and human cell-based studies directly demonstrate that UA improves mitochondrial health in human knee joint chondrocytes from OA patients, reduces cartilage degeneration and synovial inflammation in animal models, and attenuates joint destruction in rheumatoid arthritis models. Clinical arthritis RCTs are in development.
vitamin B3 (niacin)Scientific
Niacinamide has been tested in a double-blind RCT specifically for osteoarthritis, showing significant improvement in global joint impact, increased range of motion, and reduced inflammatory markers (ESR). Anti-inflammatory activity via GPR109A and inhibition of nitric oxide synthase in synovial tissue is proposed as the mechanism. Observational data also link higher dietary niacin to lower rheumatoid arthritis prevalence.
vitamin CScientific
Vitamin C is an essential cofactor for collagen synthesis and cartilage matrix formation, and acts as an antioxidant in joint fluid. Evidence from animal models, epidemiological studies, and in vitro work supports a chondroprotective role, though clinical RCT evidence for osteoarthritis is limited and not conclusive.
wasabiScientific
Wasabi's 6-MSITC suppresses COX-2, iNOS, NF-κB, and pro-inflammatory cytokines central to synovial joint inflammation in arthritis. These mechanistic anti-inflammatory effects, while demonstrated in vitro and in animal tissues, directly target the inflammatory pathways driving cartilage degradation and joint pain. Traditional use for pain relief in Japan adds supporting context.
white willowScientific
White willow bark has direct clinical trial evidence for joint pain relief, with RCTs conducted in hip and knee osteoarthritis patients showing statistically significant pain reduction versus placebo. A 2023 PMC meta-analysis of 329 arthritis patients confirmed significant joint pain relief and physical status improvement. German Commission E approves it for rheumatic ailments involving joints.
willowScientific
Joints are the primary anatomical target of willow bark's clinical evidence base. Multiple RCTs and meta-analyses have examined willow bark in osteoarthritis (hip, knee), and the EMA formally recognizes it for minor joint pain. The 2023 meta-analysis (6 RCTs, 329 arthritis patients) demonstrated significant pain relief and improved physical status. Mechanisms include COX-2 inhibition in synovial tissue, TNF-α suppression, NF-κB blockade, and MMP inhibition in chondrocytes.
wintergreenScientific
Methyl salicylate is FDA-approved for topical joint pain relief and is indicated for arthritis and joint pain. Clinical evidence includes a 30% methyl salicylate cream RCT in knee osteoarthritis and the large n=3,515 Phase IV trial demonstrating significant VAS reduction. Traditional use of wintergreen for joint and rheumatic conditions is extensively documented.
withanolidesScientific
Withanolides are steroidal lactones from Ashwagandha (Withania somnifera) responsible for its anti-inflammatory and joint-protective effects. Withaferin A inhibits NF-κB and COX-2, reducing IL-1β and MMP activity in chondrocytes. RCT evidence in knee OA patients using withanolide-standardized extracts shows significant WOMAC improvements.
yerba mateScientific
Yerba mate's anti-inflammatory polyphenols (quercetin, rutin, chlorogenic acids) inhibit NF-κB signaling and suppress pro-inflammatory cytokines relevant to joint disease. A 2025 systematic review found preliminary human evidence of reduced inflammation markers in studies relevant to RA pathophysiology.
yuccaScientific
Joints are the primary anatomical target of yucca's documented clinical effects. The 1975 Bingham double-blind trial specifically measured joint pain, swelling, and stiffness outcomes. Yucca saponins and phenolics inhibit the inflammatory cascades (NFκB, COX-1/2, 5-LOX) responsible for synovial inflammation in OA and RA. Traditional use for joint pain spans multiple Native American cultures.
zanthoxylumScientific
Joint health effects of Zanthoxylum are supported by preclinical analgesic/anti-inflammatory evidence in arthralgia models and by extensive TCM and global ethnobotanical documentation for rheumatism and joint pain. Z. nitidum extract reduced paw edema and inflammation in a chronic inflammatory joint pain model. No human joint disease trials exist.
abies spectabilisTraditional
Rheumatism affecting joints is a traditional indication for A. spectabilis in Himalayan folk medicine. Preclinical COX inhibition and anti-inflammatory data provide mechanistic support for joint-protective potential.
acemannanTraditional
Aloe vera (the source of acemannan) has traditional use in various cultures for joint pain and inflammatory conditions. Published acemannan-specific joint or arthritis research is limited to in vitro and indirect anti-inflammatory evidence; no clinical trials specifically targeting joints with acemannan have been identified.
agrimonyTraditional
Agrimony has been traditionally used for rheumatism and joint pain in European folk medicine, attributed to its anti-inflammatory properties. In vitro studies confirm suppression of pro-inflammatory cytokines. This remains a traditional indication with no clinical trial data.
alfalfaTraditional
Alfalfa is traditionally used for joint conditions including osteoarthritis and rheumatoid arthritis, documented in pharmacological monographs and across Ayurvedic and early American herbalism. Anti-inflammatory flavonoid mechanisms provide plausibility. No clinical joint outcome trials exist.
allspiceTraditional
Allspice is consistently documented in traditional herbal medicine for joint pain, soreness, and rheumatism across Caribbean, Central American, and Ayurvedic traditions. Eugenol and β-caryophyllene provide mechanistically plausible anti-inflammatory and analgesic effects relevant to joints. Preclinical anti-inflammatory data support these traditional uses.
bambooTraditional
Bamboo is used for joint pain and inflammatory joint conditions in Ayurveda, TCM, Siddha, and Unani medicine. Anti-inflammatory bioactives in bamboo (flavonoids, phenolic acids) inhibit COX-1, COX-2, and NF-κB—pathways central to joint inflammation. Preclinical data supports anti-inflammatory mechanisms, but no human joint trial exists.
barleyTraditional
Barley grass is documented in traditional and folk medicine systems as having anti-inflammatory and anti-gout properties, including reducing uric acid levels. Anti-inflammatory constituents (saponarin, SOD, polyphenols) support this traditional use, though dedicated human RCT evidence in joint disease is lacking.
basilTraditional
Basil is used in Ayurveda and traditional medicine for joint pain and arthritis. Fixed oil of O. basilicum inhibits both COX and LOX pathways in pharmacological studies, providing mechanistic plausibility for anti-arthritic and joint anti-inflammatory effects. No human clinical trials in joint disease exist.
belleric myrobalanTraditional
Belleric myrobalan has traditional use for joint-affecting conditions including rheumatism and arthritis across Ayurveda, Unani, and traditional Chinese medicine. Seed oil is traditionally applied for rheumatism. Anti-inflammatory mechanisms (lipoxygenase inhibition, TNF-α suppression) provide pharmacological plausibility. Uric acid reduction (clinically demonstrated) may benefit gout-related joint inflammation.
betelTraditional
Betel leaf is traditionally applied as a poultice and consumed as a decoction for joint pain and arthritis across South and Southeast Asia, particularly in Malaysia. Preclinical anti-inflammatory and analgesic studies in rodents support the mechanistic plausibility, but human clinical evidence is absent.
bilberryTraditional
Bilberry is used in European herbal medicine for inflammatory joint conditions including osteoarthritis and rheumatoid arthritis, based on its anthocyanoside-mediated collagen-protective and anti-inflammatory properties. The Restorative Medicine bilberry monograph specifically mentions treatment of inflammatory joint conditions. Dedicated RCTs in joint disease populations are not available.
birchTraditional
Birch is traditionally and formally (ESCOP, German Commission E) indicated for rheumatic conditions affecting the joints. Betulin and betulinic acid's anti-inflammatory activity via COX-2 inhibition is directly relevant to joint inflammation. Diuretic-driven uric acid elimination addresses the joint pathology of gout.
black cohoshTraditional
Black cohosh has traditional documentation for joint pain and arthritis relief from multiple cultures. The MHRA and NIH ODS both list joint-related conditions among its traditional indications. Limited clinical data from a combination-herb trial suggest some benefit in osteoarthritis, but black cohosh monopreparation evidence for joints is sparse.
black spruceTraditional
Black spruce is used in aromatherapy for joint pain and swelling, including in conditions such as arthritis. Its constituents bornyl acetate and α-pinene have published anti-inflammatory and chondroprotective activity in joint-relevant cell models. Traditional topical application in massage blends is well documented.
blackberryTraditional
Blackberry has been used since antiquity for gout (a joint disease), with documentation from ancient Greek physicians through European and Native American herbalism. Its anti-inflammatory polyphenols and uric-acid-modulating vitamin C and quercetin provide mechanistic plausibility for joint symptom relief, though clinical trials are absent.
bladderwrackTraditional
Bladderwrack has a documented traditional use for inflamed and painful joints, applied both orally and as topical compresses. Fucoidan reduces joint swelling and inflammatory mediators in animal arthritis models. Human joint-specific clinical trials are absent.
bonesetTraditional
Boneset was used historically by settlers and Eclectic physicians for rheumatism and arthritis affecting joints, as documented by Drugs.com, Lockwood (1847), and Florida School of Holistic Living sources. In vitro anti-inflammatory data on cytokine downregulation provides biological plausibility for joint inflammation. No clinical trials exist for joint-specific outcomes.
buchuTraditional
Buchu has a long tradition of use for joint-related complaints including rheumatism and arthritis among Khoisan peoples and European settlers. Preclinical in vitro data support anti-inflammatory mechanisms (COX and 5-LOX inhibition) relevant to joint inflammation. No human joint-specific trials have been conducted.
caesalpinia cristaTraditional
C. crista is traditionally used across South and Southeast Asian ethnomedicine for joint-related conditions including rheumatism and arthritis. Indonesian ethnomedicine uses root decoction as a tonic for rheumatism. Preclinical anti-inflammatory evidence provides indirect scientific support.
cajuputTraditional
Cajuput oil's use for joint pain is documented across Southeast Asian, Aboriginal Australian, Ayurvedic, and European traditional medicine, and it is registered for joint pain (rheumatism) in topical preparations by Natural Medicines/RxList. It is a component of Tiger Balm used for arthritic joint pain. Pharmacological counter-irritant and anti-inflammatory mechanisms are grounded.
calendulaTraditional
Calendula is traditionally used topically for joint inflammation, sprains, and musculoskeletal discomfort. Its anti-inflammatory and analgesic properties are demonstrated in animal models. It is a constituent of Traumeel, used for musculoskeletal injuries. No standalone RCTs for joint conditions exist.
cassia barkTraditional
Cassia bark is documented in TCM as relieving joint pain through its circulation-improving and cold-dispersing properties. Animal studies support anti-inflammatory mechanisms relevant to joint inflammation. No clinical trials specifically for joint conditions using C. cassia bark were identified.
celeryTraditional
Celery has been used in traditional Western, Ayurvedic, and TCM medicine for arthritis, gout, and rheumatism for centuries. A rodent study confirmed suppression of uric acid and joint swelling in gout models. Anti-inflammatory flavonoids and diuretic apiol provide plausible mechanisms, but human joint RCTs are absent.
centella asiaticaTraditional
Centella asiatica (Gotu Kola) is traditionally used in Ayurveda and TCM for joint pain, connective tissue repair, and inflammation. Triterpene glycosides (asiaticoside, madecassoside) stimulate collagen synthesis and have anti-inflammatory properties relevant to joints.
chamomileTraditional
Chamomile has been traditionally used for joint pain and rheumatic conditions including gout and rheumatoid-type inflammation. Preclinical models show chamomile reduces arthritis scores and cytokine levels comparably to indomethacin via COX-2 and iNOS downregulation. Traditional Persian medicine specifically recommends chamomile for joint pain. Human clinical trials focused on joint outcomes are not yet established.
chickweedTraditional
Chickweed has well-documented traditional use for joint pain and inflammation, particularly rheumatic joints, in European and homeopathic systems. Preclinical anti-inflammatory and analgesic data support plausibility. A preliminary clinical study also included arthritic patients.
clerodendrum indicumTraditional
C. indicum is traditionally used for rheumatism and arthritis across India, Myanmar, and Southeast Asia, with the gum specifically noted as antirheumatic. The genus review documents 'arthrophlogosis' (joint inflammation) as a historical indication for C. indicum. Preclinical genus-level evidence supports anti-inflammatory mechanisms relevant to joint disease.
dandelionTraditional
Dandelion has documented traditional use for joint and rheumatic conditions in European, Arabian, Chinese, and North American herbal traditions. Anti-rheumatic properties are listed in ESCOP and referenced by Health Canada. The German Commission E acknowledges anti-rheumatic historical use. No joint-specific clinical trials exist.
dioscoreaTraditional
Wild yam has an extensively documented traditional use for joint pain and arthritis. In vitro evidence shows diosgenin protects articular cartilage and induces apoptosis in RA synoviocytes. Animal studies confirm anti-inflammatory effects. Human joint trials are absent.
dipsacusTraditional
Dipsacus (Japanese teasel root, Xu Duan) is used in traditional Chinese medicine to strengthen bones and joints, treat arthritis, and support connective tissue repair. Classical TCM texts classify it as tonifying kidneys and bones. Modern animal studies show anti-OA effects, though human RCT evidence is limited.
dogwoodTraditional
Jamaican dogwood has documented traditional use for inflammatory rheumatism and joint pain, applied both topically and internally. Cornus officinalis is used in TCM for waist and knee weakness attributed to kidney-essence deficiency. Preclinical anti-inflammatory data support the mechanism. No joint-specific clinical trials exist.
drynariaTraditional
Drynaria (Gu Sui Bu) is a traditional Chinese medicine herb used for bone fractures, joint injuries, and arthritis. Its active naringenin glycosides and flavonoids promote osteoblast activity and have anti-inflammatory effects in joint tissue. Animal studies show cartilage-protective effects in OA models.
eucommiaTraditional
Eucommia ulmoides (Du Zhong) is a classical TCM tonic herb for bones, joints, and kidneys. Traditional texts prescribe it for joint pain, osteoarthritis, and back weakness. Active constituents (chlorogenic acid, aucubin, geniposidic acid) have anti-inflammatory and anti-OA effects in animal models.
eucommia ulmoidesTraditional
Eucommia ulmoides (Du Zhong) bark is a primary TCM herb for joint and bone conditions. Used for 2,000+ years for knee/back pain, joint weakness, and arthritis. Modern studies confirm anti-inflammatory and chondroprotective properties via NF-κB and MMP pathway modulation.
european elderTraditional
Elderberry has documented traditional use for rheumatism, gout, and joint swelling dating to medieval European herbal medicine. Preclinical anti-inflammatory activity—including in vivo granuloma reduction comparable to diclofenac—provides mechanistic support. No clinical trials in humans with joint conditions are available.
fulvic acidTraditional
Centuries of European balneotherapy with peat (rich in humic and fulvic acids) specifically targets joint and rheumatic diseases. Humic substances reportedly bond to collagen fibers to aid repair of damaged tendons and bone, though modern RCT evidence for isolated fulvic acid in joint disease is lacking.
gooseberryTraditional
Traditional Ayurvedic medicine has documented amla for joint conditions—osteoarthritis (WebMD/NLM documented use), inflammatory arthritis, and joint pain—under the classical category of vata and amavata disorders. Anti-inflammatory clinical evidence indirectly supports this use.
gotu kolaTraditional
Gotu Kola (Centella asiatica) is traditionally used in Ayurvedic and traditional Chinese medicine for joint inflammation, connective tissue repair, and arthritis. Active triterpenes (asiaticoside, asiatic acid, madecassoside) promote collagen synthesis and have anti-inflammatory effects relevant to joint connective tissue.
greek mountain teaTraditional
GMT has documented traditional use for rheumatic joint conditions across the Balkan Peninsula, listed in the 2023 systematic monograph and multiple peer-reviewed ethnobotanical reviews. Preclinical anti-inflammatory data comparable to indomethacin provide pharmacological plausibility for joint inflammation. No human joint-specific clinical data exist.
hedychium spicatumTraditional
H. spicatum is documented in Ayurvedic and folk tradition for joint discomfort and rheumatic conditions, with the rhizome recorded as used for 'joint discomfort' in multiple reviews. Preclinical anti-inflammatory data (carrageenan-induced paw edema reduction, prostaglandin/cytokine suppression) provide indirect mechanistic support.
hollyTraditional
Holly leaves are documented across multiple traditional European herbalism sources for both internal and external use for joint pain, rheumatism, swelling, and gout. Triterpenoids and flavonoids in the plant provide partial biological plausibility for anti-inflammatory effects in joints.
honeysuckleTraditional
Honeysuckle stems (Ren Dong Teng) are specifically indicated in TCM and the Korean Pharmacopoeia for wind-damp arthritis affecting joints. Preclinical evidence shows inhibition of NF-κB and JAK/STAT pathways in synovial cells. Anti-inflammatory and antinociceptive properties are documented.
horse chestnutTraditional
Horse chestnut has a long-standing traditional application for joint pain and arthritic conditions in European and Asian herbal medicine. The anti-inflammatory properties of aescin and the leaf's traditional antipyretic use extend to joint inflammation, but no clinical trials in joint disease specifically have been conducted.
horseradishTraditional
Horseradish has a traditional role as a topical remedy for joint pain and swelling, officially recognised by the German Commission E. Applied as a rubefacient poultice, it increases local circulation and provides counter-irritant pain relief for arthritic and rheumatic joints. In vitro anti-inflammatory effects support the mechanism.
horsetailTraditional
Horsetail has a long traditional use for joint health, grounded in the role of silica in supporting cartilage matrix and connective tissue collagen. Herbalists have historically used it for joint flexibility and in degenerative joint conditions. Preclinical anti-inflammatory evidence is supportive, but no clinical trials have measured joint-specific outcomes.
hydrangeaTraditional
Hydrangea is documented in TCM and Western herbalism for joint-related conditions including arthritis, gout, and rheumatoid arthritis. The Th17/halofuginone preclinical data from the related species D. febrifuga provides a mechanistic scientific context for joint inflammatory diseases. Traditional use is well-documented; human clinical evidence for joint outcomes is absent.
immortelleTraditional
H. italicum is used in Mediterranean folk medicine for joint pain and inflammation. Its potent in vitro and in vivo inhibition of COX, 5-LOX, and NF-κB provides strong mechanistic plausibility for joint anti-inflammatory benefit, and early research is noted for muscle and joint inflammation, but no human joint-specific clinical trials exist.
indian baelTraditional
Traditional Ayurvedic and folk medicine documents bael preparations for swollen joints, rheumatism, and musculoskeletal pain. Multiple pharmacological reviews list anti-arthritis activity as a documented property of AM, and its anti-inflammatory mechanisms provide mechanistic support for joint health applications.
indian sarsparillaTraditional
Joint health is a primary traditional indication of H. indicus in Ayurveda, Siddha, and Unani medicine for rheumatism and arthritis. Topical paste application to swollen rheumatic joints is a classical preparation. Anti-arthritic and anti-osteoclastic activity have been demonstrated in preclinical studies.
indian tinosporaTraditional
T. cordifolia is a longstanding traditional remedy for joint pain, arthritis, and gout across Ayurveda, Siddha, and Southeast Asian folk medicine. Its anti-inflammatory alkaloids are mechanistically relevant to joint inflammation. It is commonly used in combination preparations for rheumatoid arthritis and gout. Preclinical data confirm anti-arthritic and uric acid-lowering effects.
indigo leavesTraditional
Indigo (I. tinctoria) is documented in Ayurvedic and Siddha medicine for joint conditions including rheumatoid arthritis, gout, and lumbago. Anti-arthritic activity has been demonstrated in animal models of the genus. Anti-inflammatory mechanisms involving JAK/STAT3 and Th17 suppression are relevant to joint inflammation.
lemongrassTraditional
Lemongrass is classified as antirheumatic in pharmacological reviews and used in folk medicine for joint pain, rheumatic complaints, and muscle spasms. COX-I, COX-II, and 5-LOX inhibitory activity provides preclinical mechanistic support. No human clinical trials for joint conditions exist.
lilacTraditional
European ethnopharmacology extensively documents lilac infusions, decoctions, and alcoholic extracts for joint aches, rheumatism, and gout across multiple countries. Hungarian records specifically note use of S. vulgaris leaves for joint and muscle aches. Preclinical anti-inflammatory data support biological plausibility.
limeTraditional
Lime is traditionally used for joint pain and gout in Southeast Asian and Ayurvedic medicine, attributed to its citric acid dissolving urate crystals and its flavonoids reducing joint inflammation. The Springer Citrus aurantifolia review notes it 'may alleviate conditions like arthritis.' Dedicated human RCTs for lime on arthritis endpoints are absent.
malabar nutTraditional
A. vasica leaf poultices are applied to joints in traditional practice for rheumatic symptoms, and antiarthritis properties are documented in multiple ethnopharmacological reviews. Vasicine's anti-inflammatory mechanisms provide pharmacological plausibility.
mangoTraditional
Mango is documented in Ayurvedic and folk medicine traditions for rheumatism and joint pain management. Mangiferin's anti-inflammatory properties in preclinical studies offer mechanistic plausibility, but human clinical trial evidence for mango's effects on joint conditions is lacking.
maqui berryTraditional
Mapuche traditional medicine documented topical and oral use of maqui for joint pain and inflammation, consistent with its anti-inflammatory pharmacology. Modern preclinical data support inhibition of TNF-α, IL-6, and iNOS—key mediators of joint inflammation. No human clinical trial for joint disease has been conducted with maqui.
marjoramTraditional
Marjoram is used in traditional medicine across Moroccan, Ayurvedic, and European systems for joint pain and rheumatism. Its anti-inflammatory and analgesic properties provide a pharmacological basis for topical applications.
milkweedTraditional
Milkweed was used in Indigenous North American medicine and 19th-century herbal practice for rheumatic joint complaints. Cooked stems were applied as a poultice to rheumatic joints, and root decoctions were taken internally for arthritis and rheumatism. Preclinical anti-inflammatory data from A. curassavica provides a partial mechanistic rationale. No clinical evidence exists.
momordicaTraditional
Momordica charantia is documented in traditional medicine for rheumatism and gout, both of which primarily affect joints. Anti-inflammatory preclinical evidence supports biological plausibility. A U.S. patent describes M. charantia seed oil as an anti-arthritic agent. No human clinical trials exist.
morusTraditional
Morus alba twigs (Sang Zhi) are a classical TCM herb for joint pain, numbness, and wind-bi (wind-damp obstruction) conditions corresponding to arthritis and rheumatic complaints. Their use is documented in the Chinese Pharmacopoeia and multiple TCM sources, supported by in vitro anti-inflammatory evidence.
mulberryTraditional
Mulberry twig (Sang Zhi) is a formal TCM herb specifically for joint pain, stiffness, and swelling, listed in the Chinese Pharmacopoeia with documented use in Bi syndrome (rheumatic joint conditions). Preclinical evidence supports anti-inflammatory constituents in mulberry twigs.
neem treeTraditional
Neem is used in Ayurvedic and folk medicine for joint pain, documented in the Indian Journal of Dermatology. The ScienceDirect overview notes antiarthritic activity of neem seed oil. Anti-inflammatory COX/LOX inhibition and cytokine modulation provide mechanistic plausibility. Human clinical trials for joint conditions specifically are absent.
nopalTraditional
Nopal heated poultices have traditional use for rheumatic disorders and arthritis in Mexican and other ethnomedicinal traditions. Anti-inflammatory compounds (polyphenols, betalains, omega-3 linolenic acid) provide biological plausibility for joint inflammation modulation. No controlled human clinical trials evaluating nopal for joint disease have been identified.
oreganoTraditional
Oregano has traditional documentation for use in rheumatic and joint pain across Balkan, Middle Eastern, and folk herbal traditions, applied as a topical liniment or oral infusion. Carvacrol's COX-2 inhibitory and NF-κB suppressing activities provide a pharmacological rationale for anti-inflammatory effects at joints. No human clinical trials for joint outcomes have been published.
oriental arborvitaeTraditional
P. orientalis is traditionally used for rheumatism and joint pain across multiple Asian medical systems. Anti-inflammatory pharmacology—including inhibition of COX, LOX, and TNF-α—is relevant to joint inflammation. Both traditional records and mechanistic preclinical data support this association.
papainTraditional
People with arthritis and inflammatory joint conditions have reported symptom relief with papain. Proteolytic enzymes including papain are proposed to dissolve intra-articular immune complexes and fibrinous exudates. Traditional and folk medicine use of papain for joint swelling and stiffness is documented. Clinical trial evidence specifically in joint disease populations has not been established.
papayaTraditional
Papaya leaves and seeds are used in traditional medicine across tropical regions for joint pain and arthritis, attributed to anti-inflammatory phytochemicals including flavonoids, alkaloids, and papain. Preclinical anti-inflammatory data support plausibility, but no human RCT has specifically evaluated papaya for joint conditions.
parsleyTraditional
Parsley is listed in traditional and ethnopharmacological literature as antirheumatic, and its anti-inflammatory flavonoids (apigenin, luteolin, kaempferol) provide a plausible biological mechanism for reducing joint inflammation. Animal model evidence shows anti-inflammatory activity relevant to arthritic conditions.
perillaTraditional
Rosmarinic acid, the primary polyphenol of Perilla, is described in the literature as potentially beneficial for rheumatoid arthritis and other autoimmune joint diseases via NF-κB suppression and anti-inflammatory mechanisms. Traditional Ayurvedic medicine used perilla for anti-inflammatory purposes including joint conditions. Clinical evidence specific to joint disease is absent.
plantainTraditional
Plantago lanceolata is documented as a traditional remedy for arthritis and joint inflammation. Anti-inflammatory mechanisms relevant to joints—COX-1/COX-2 inhibition, NF-κB suppression, complement inhibition—are pharmacologically characterized. Traditional use for rheumatism and joint pain is documented globally. No dedicated joint health RCT with Plantago exists.
pterocarpus marsupiumTraditional
P. marsupium is traditionally used for joint disorders including arthritis, rheumatoid arthritis, and gout in Ayurvedic and ethnobotanical medicine. Anti-inflammatory preclinical pharmacology provides indirect support.
red cloverTraditional
Red clover has a consistently documented traditional use for joint conditions including arthritis, gout, and rheumatism across European and Asian herbal traditions. Multiple monograph sources list joint pain among its indications. Anti-inflammatory isoflavone mechanisms provide biological plausibility but no dedicated joint-focused clinical trials exist.
rehmannia glutinosaTraditional
Rehmannia has documented use for joint diseases in TCM, including rheumatoid arthritis and osteoarthritis. The dried root has 'a long history of safe use in traditional folk medicine for the treatment of joint diseases.' Anti-inflammatory mechanisms provide biological plausibility.
sageTraditional
Sage has a documented traditional use for rheumatic joint pain and arthritis across European, Asian, and Latin American folk medicine traditions, attributed to its anti-inflammatory and antinociceptive properties. Preclinical evidence supports anti-inflammatory mechanisms. No human RCTs on joint disease could be identified.
scrophularia rootTraditional
Scrophularia root has documented traditional use for joint-related disorders including rheumatism, arthritis, and gout across Asian and European traditions. S. buergeriana has demonstrated bone disorder prevention activity in preclinical models. In vitro anti-inflammatory activity is mechanistically relevant to joint inflammation.
silk treeTraditional
A. julibrissin has traditional use for rheumatism and joint-related conditions across Asian and African medicine systems, and related Albizia species are used for rheumatic complaints. It may also be used for degenerative joint and muscle diseases in TCM practice.
skullcapTraditional
Baicalin and baicalein inhibit NF-κB, COX-2, and pro-inflammatory cytokines relevant to synovial joint inflammation. S. baicalensis is used in TCM for arthritis and osteoarthritis; recent collagen-induced arthritis (CIA) rat models show baicalin significantly reduces joint symptoms. Human joint disease trials with single-herb skullcap are limited.
smartweedTraditional
Joint pain, rheumatoid arthritis, and joint-related conditions are documented traditional indications for P. hydropiper across Asian and European folk medicine. The plant is used as an anti-rheumatic agent, and its anti-inflammatory preclinical data lend mechanistic plausibility.
solomon's sealTraditional
Joints are the most consistently cited anatomical target of Solomon's seal across European, TCM, North American, and Ayurvedic traditions. The herb is used for arthritis, sprains, dislocations, and general joint pain and stiffness. In vitro anti-inflammatory activity supports the traditional use.
spruceTraditional
Spruce resin poultices and bark decoction steam baths have documented traditional use for rheumatic joint pain across Native North American and European traditions. Multiple spruce species (Sitka, white, Norway) are recorded for joint complaints. Anti-inflammatory terpene and polyphenol constituents provide mechanistic rationale for joint applications.
stillingiaTraditional
Stillingia was traditionally used for chronic joint and periosteal rheumatism in Eclectic and homeopathic medicine, applied both internally and as a topical liniment. It was considered specific for chronic, non-acute joint complaints. No clinical evidence supports this use.
sweet flagTraditional
A. calamus is used traditionally for joint diseases including rheumatism, rheumatoid arthritis, and neuralgia across Ayurveda, Chinese medicine, and Unani traditions. Anti-inflammatory and analgesic preclinical properties provide pharmacological support.
tylophoraTraditional
Tylophora is used in Ayurveda and regional Indian folk medicine for rheumatism, joint pain, and arthritis, with topical poultices applied to arthritic joints in Andhra Pradesh and Karnataka. Preclinical studies show the flavone fraction inhibits adjuvant-induced arthritis lesions in rats, providing pharmacological support for the joint-related traditional use.
watercressTraditional
Watercress is extensively documented as a traditional remedy for joint pain, arthritis, and rheumatic conditions across Iranian, Moroccan, Turkish, European, and other folk medicine traditions. Topical and internal applications are both recorded. Mechanistic support comes from anti-inflammatory activity of PEITC and quercetin. No joint-specific human clinical trial exists.
wheat grassTraditional
Wheatgrass is used in traditional and naturopathic medicine for joint conditions including arthritis and gout, citing anti-inflammatory properties. Folk medicine traditions specifically mention gout alleviation. Some limited clinical data mention symptom reduction in rheumatoid arthritis.
white oakTraditional
White oak bark has traditional use for joint pain and arthritis, consumed as a tea for its anti-inflammatory properties. The anti-inflammatory and analgesic activity of oak polyphenols in laboratory models supports the mechanistic rationale. No clinical trials in joint conditions have been conducted.
wild yamTraditional
Wild yam has an established traditional use for inflammatory joint conditions, particularly rheumatoid arthritis and general joint pain, referenced by its folk name 'rheumatism root.' In vitro studies suggest diosgenin protects against arthritis progression in joint cells. Human evidence is lacking.
wood betonyTraditional
Wood betony has traditional use for joint pain including arthritis, gout, and rheumatism. Renaissance pharmacopoeias included it in remedies specifically for arthritis and gout. In vitro COX and lipoxygenase inhibition provides a phytochemical basis.
xanthium (cockleburs)Traditional
Joint pain from arthritis, rheumatism, and rheumatoid arthritis has been a documented traditional indication in TCM, Indian Ayurveda, and South Asian folk medicine for X. strumarium. The plant is listed in the Chinese Pharmacopoeia for these conditions, and preclinical analgesic data support use for joint-related pain.
yarrowTraditional
Yarrow is used traditionally for rheumatic joint pain and swelling in Persian and European folk medicine. Its COX-inhibiting, MMP-suppressing, and analgesic pharmacology provides a well-grounded mechanistic rationale relevant to joint inflammation.

Other Names

Synopsis

Joints: Anatomy, Physiology, Health Assessment, and Nutritional Support

1. Definition and Overview

2. Classification of Joints

2.1 Structural Classification

2.2 Functional Classification

2.3 Subtypes of Diarthrotic (Synovial) Joints by Axes of Motion

3. Structure and Components of Synovial Joints

3.1 Articular Capsule

3.2 Articular Cartilage

3.3 Synovial Fluid

3.4 Ligaments, Bursae, and Other Accessory Structures

3.5 Damage Response

4. Physiological Functions of the Joint System

5. Joint Movements

6. Assessment of Joint Health

6.1 Clinical and Physical Examination

6.2 Imaging Modalities

6.3 Factors Supporting Normal Joint Function

7. Common Conditions and Disorders of the Joint System

7.1 Osteoarthritis (OA)

7.2 Rheumatoid Arthritis (RA)

7.3 Gout

7.4 Other Joint Conditions

8. Nutrients, Herbs, and Natural Ingredients Used to Support Joint Health

8.1 Glucosamine and Chondroitin

Traditional and Historical Use

Scientific Evidence

8.2 Curcumin (Turmeric, Curcuma longa)

Traditional Use

Scientific Evidence

8.3 Boswellia (Boswellia serrata)

Traditional Use

Scientific Evidence

8.4 Omega-3 Polyunsaturated Fatty Acids (Fish Oil)

Traditional Use

Scientific Evidence

8.5 Collagen (Undenatured Type II Collagen)

Traditional Use

Scientific Evidence

8.6 Methylsulfonylmethane (MSM)

Traditional Use

Scientific Evidence

8.7 Hyaluronic Acid

Traditional Use

Scientific Evidence

8.8 Vitamin D

Traditional Use

Scientific Evidence

8.9 Summary Table: Evidence Strength for Key Ingredients

References

Natural Remedies

Ingredients

Stay informed. Stay healthy.